American College of Medical Toxicology 2012 www.acmt.net
ACMT Medical Toxicology Board Review Course
ARE YOU PREPARED? Astor Crowne Plaza Hotel New Orleans, LA September 8-10, 2012 SYLLABUS
Day Two - 3 slides per page
Sponsored by the University of Alabama School of Medicine Division of Continuing Medical Education American College of Medical Toxicology Medical Toxicology Board Review Course September 8-10, 2012 - New Orleans, LA
Day 1 - Saturday, September 8, 2012 7:00-7:50am Breakfast & Stimulus Room 7:50-8:20am Welcome & Introductions 8:20-9:10am Pharmacokinetics/Toxicokinetics Howard A. Greller, MD, FACMT 9:10-10:00am Molecular Mechanisms William P. “Russ” Kerns II, MD, FACMT 10:00-10:20am Break 10:20-11:10am Analytical/Forensics Evan S. Schwarz, MD 11:10-12:00pm Autonomics/Neurotransmitters G. Patrick Daubert, MD 12:00-1:30pm Lunch –n-Learn: Mushrooms & Fish-borne Howard A. Greller, MD, FACMT 1:30-2:20pm Psychotropics G. Patrick Daubert, MD 2:30-3:20pm Cardiovascular Toxins Trevonne M. Thompson, MD 3:20-3:40pm Break 3:40-4:05pm Hydrocarbons Trevonne M. Thompson, MD 4:05-4:30pm Pharmaceutical Additives G. Patrick Daubert, MD 4:30-4:55pm Endocrine Trevonne M. Thompson, MD 6:00-7:30pm Welcome Reception - Napoleon House, 500 Chartres Street in the French Quarter
Day 2 - Sunday, September 9, 2012 7:00-8:00AM Breakfast & Stimulus Room 8:00-8:50am Pesticides J. Dave Barry, MD, FACMT 8:50-9:15am Terrorism Hazmat J. Dave Barry, MD, FACMT 9:15-9:40am Antimicrobials Michael Policastro, MD 9:40-10:00am Break 10:00-10:50am GI/Heme Michael Policastro, MD 10:50-11:15am Chemotherapeutics Michael Policastro, MD 11:15-12:05pm Plants Thomas C. Arnold, MD, FACMT 12:05-1:30pm Lunch-n-Learn: Historical Outbreaks Stephen W. Munday, MD, MPH FACMT 1:30-2:20pm Envenomations Thomas C. Arnold, MD, FACMT 2:20-3:10pm Carcinogens Stephen W. Munday, MD, MPH, FACMT 3:10-3:30pm Break 3:30-4:20pm Misc Toxins 1 Brandon K. Wills, DO, FACMT 4:20-4:45pm Misc Toxins 2 Brandon K. Wills, DO, FACMT
Day 3 - Monday, September 10, 2012 7:00-8:00am Breakfast & Stimulus Room 8:00-8:50am Anesthetics; Drugs of Abuse & Withdrawal Kurt C. Kleinschmidt, MD, FACMT 8:50-9:15am Herbal/Supplemental Tox Kurt C. Kleinschmidt, MD, FACMT 9:15-10:05am Industrial Poisons Jefrey Brent, MD, PhD, FACMT 10:05-10:25am Break 10:25-11:15am Assessment/Population Health/Risk Jefrey Brent, MD, PhD, FACMT 11:15-12:05pm Metals/Metalloids 1 Cyrus Rangan, MD 12:05-12:30pm Metals/Metalloids 2 Cyrus Rangan, MD John G. Benitez, MD, MPH, FACMT 12:30-3:00pm Stimulus Room Russ Kerns, MD, FACMT Pesticides
ACMT Board Review Course
J. Dave Barry Naval Medical Center Portsmouth Portsmouth, VA
2
Pesticides
Insecticides Fungicides
Rodenticides Fumigants
Herbicides Others
3
1 Pesticides
Insecticides
Cholinesterase Inhibitors Organophosphates Carbamates Organochlorines Pyrethrins/Pyrethroids Newer Insecticides
4
Insecticides Cholinesterase Inhibitors
O Carbamates R1 Ordeal (Calabar) Bean R-O C N (or S) R2 Carbamates
Organophosphates O (or S) Synthesized R2 P R1 X Organophosphates 5
Insecticides Cholinesterase Inhibitors
6 Goldfrank’s Toxicologic Emergencies – 8th Ed (2006)
2 Pesticides
sympathetic Autonomic Nervous System parasympathetic
N M M C
N T ne
N ne L
N M S
N 7
Sympathetic Parasympathetic (cholinergic)
agit N M Sz M C sec mio
N T sec rr ne
sec vasoconstr hr N hr ne L
mot N M S sec Fasic N 8 paraly mict
Insecticides Organophosphates Delayed Syndromes Intermediate Syndrome Weakness 1-4d after exposure peripheral NMJ dysfunction ineffective AChE reactivation
OPIDN Neuropathy target esterase (NTE) Lysophospholipase (lysoPLA) TOCP (tri-ortho cresyl phosphate) Jamaican ginger paralysis (1930’s) Cooking oils (1950’s) 9
3 Pesticides
Insecticides Organophosphates Diagnosis RBC Cholinesterase Butyrylcholinesterase (pseudocholinesterase) Better reflection of Falls first synaptic inhibition Recovers rapidly (few days) Regenerates more Wide daily variation slowly than neuronal in other disorders AchE Liver dysfunction Wide variations Malnutrition in RBC disorders Drugs Pregnancy 10 Genetic deficiency
Insecticides Cholinesterase Inhibitor Treatment Decontamination Protect Providers Glove Bag Skin Triple wash – soap/water Shave scalp? GI Gastric? AC?
11
Insecticides Cholinesterase Inhibitor Treatment Decontamination Antimuscarinic Agents Atropine Infusion 0.02 – 0.08 mg/kg/hr Bolus 2mg q 2-15 min / double dose Glycopyrrolate Scopolamine
12
4 Pesticides
Insecticides Cholinesterase Inhibitor Treatment Decontamination Antimuscarinic Agents Benzodiazepine Diazepam
13
Insecticides Cholinesterase Inhibitor Treatment Decontamination Antimuscarinic Agents Benzodiazepine
(Organophosphates) Oximes Pralidoxime Bolus: 600mg q ?4hr Infusion: 1-2g load f/b Obidoxime, HI-6 500mg/hr
?carbaryl? 14
Insecticides Organophosphates
Aging & Oximes
R
“Aging”
15
5 Pesticides
Insecticides Organochlorines
Large family of neuroexcitatory toxins DDT and analogues
Cyclodienes
Hexachlorocyclohexane (lindane)
Mirex and chlordecone
16
Insecticides Organochlorines
Large family of neuroexcitatory toxins DDT and analogues Most banned from industrialized countries Na Ch Blockade Neuroexcitation
17
Insecticides Organochlorines
Large family of neuroexcitatory toxins
DDT and analogues Cyclodienes Most banned from industrialized countries GABA Antagonists neuroexcitation
18
6 Pesticides
Insecticides Organochlorines
Large family of neuroexcitatory toxins
DDT and analogues
Cyclodienes Hexachlorocyclohexane (lindane) Scabicide GABA Antagonist Seizures, neuroexcitation
19
Insecticides Organochlorines
Large family of neuroexcitatory toxins
DDT and analogues
Cyclodienes
Hexachlorocyclohexane (lindane) Mirex and chlordecone Hopewell Epidemic (1974) “Kepone Shakes”
20
Insecticides Pyrethrins/Pyrethroids
Pyrethrins Naturally occuring NaCh openers Rapidly decompose
Pyrethroids Synthetic derivatives More persistent, potent Piperonyl butoxide
P450 inhibitor 21
7 Pesticides
Insecticides Pyrethrins/Pyrethroids
Toxicity Pyrethrins Allergic
Pyrethroids Type 1 Type II Non-CN -CN “T” Syndrome More potent Tremor “CS” Syndrome Low tox in humans Choreoathetosis, salivation GI (saliv, n/v/d), pulmonary neuroexcitation 22
Insecticides Pyrethrins/Pyrethroids
Treatment Supportive Decontamination Skin GI - AC
23
Insecticides Others
Boric Acid Ant/cockroach killer Mechanism unclear Symptoms GI (blue-green emesis/diarrhea) Kidney CNS/Neuro Derm (boiled lobster rash)
24
8 Pesticides
Insecticides Others
Amitraz 2-agonism Treatment Fipronil supportive GABA antagonist Insect:Human 1000:1 Imidacloprid Nicotinic Avermectins (abamectin, ivermectin) Fermentation of Streptomyces avermitilis
25
Rodenticides
26
Rodenticides Compound 1080/1081
Sodium Monofluoroacetate (SMFA) Compound 1080 Flouroacetamide Compound 1081
Inhibit aconitase in Krebs cycle “lethal synthesis”
27
9 Pesticides
Compound 1080/1081
28
Rodenticides Compound 1080/1081
Symptoms apprehension dysrhythmias, seizures, coma, ↓ Ca Not flouride toxicity
Treatment Unknown
Ethanol, Glycerol 29 monoacetate,
Rodenticides PNU (Vacor)
n-3-pyridylmethyl-N-p-nitrophenyl urea Interferes with nicotinamide activity in pancreas, brain, liver
Rapid development of Diabetes mellitus (DKA) Orthostatic hypotension CNS toxicity GI perforation 30
10 Pesticides
Rodenticides PNU (Vacor)
Treatment Aggressive Decontamination
Nicotinamide
Niacin
31
Rodenticides Phosphine
Rodenticide (Zinc Phosphide) Fumigant (Aluminum Phosphide)
Phosphine gas Cellular poison Inhibits cytochrome oxidase and ETC Rotten fish / garlic-like odor
32
Rodenticides Phosphene
Symptoms
Low level exposure Pulmonary edema (delayed)
High level exposure Multisystem failure N/V, coma, seizures, hypertension, pulmonary edema
33
11 Pesticides
Rodenticides Phosphene
Treatment Inhalation – supportive
Ingestion Intubation lavage/suction diluted HCO3 solution, milk Supportive NAC, Mg
34
Rodenticides Strychnine
Strychnos nux vomica Glycine inhibition Involuntary generalized muscular contractions Opisthotonos, trismus, risus sardonicus Treatment Benzodiazepines NM Blockade
35
Rodenticides ATNU
α-naphthyl-thiourea
Acute pulmonary edema
Mechanism unknown
36
12 Pesticides
History
‘superwarfarins’ Longer T1/2 100X more potent Same mechanism
37
Warfarins Exogenous Vitamin K Vit K (phytonadione) Quinone
Vit Ki (inactive) Vit Ka (active) Vit K 2,3 epoxide hydroquinone FFP
Factors II,VII,IX,X Factors Iia,VIIa,Ixa,Xa (active)38
Diagnosis & Treatment Child/unintentional none
Suicidal/other Labs
Vit K1 (phytonadione) IV, PO, IM FFP
39
13 Pesticides
Bromethalin Uncouples oxidative phosphorylation AMS, myoclonus, seizures, coma
Norbormide (dicarboximide) Norway rat selective smooth muscle constriction Death from profound vasoconstriction Other rats, rodents, humans don’t have the same receptor or transporter
40
Herbicides
Bipyridyl herbicides Paraquat Diquat Chlorphenoxy herbicides 2,4-D, 2,4,5-T and Agent Orange Glyphosate Anilide derivatives
41
Paraquat/Diquat
Redox cycling
1 – depletion of NADPH 2 – superoxide formation 3 – lipid peroxidation cascade 4 – glutathione & NADPH depletion 42
14 Pesticides
Paraquat
Active transport into Type I & II alveolar epithelial cells
Surfactant depletion, destruction of
alveoli 43
Symptoms
Dependant on amount ingested May be delayed, especially with dilute products
Caustic (Skin, GI Mucosa)
Renal Toxicity/Failure ARDS
Paraquat – pulmonary fibrosis CNS (somnolence, coma, sz, etc) Diquat – predilection for pontine hemorrhage?
44
Treatment Skin Decon Lavage (N/V usually occur though) AC, Fuller’s earth, bentonite, garden clay Hemodialysis, hemoperfusion, hemofiltration
?No O2 until PaO2 < 50mm Hg
45
15 Pesticides
chemical analogs of auxins (a plant growth hormone) Uncontrolled and lethal growth
46
Corrosive, cell membrane damage form Acetyl Co-A analogues, uncouple oxid phos?
Symptoms Treatment GI supportive N/V, abdominal pain, diarrhea CV hypotension, nonspecific ECG abnormalities CNS coma, hypertonia, hyperreflexia,
Ukrainian opposition 47 presidential candidate Viktor Yushchenko
Plant mechanism – amino acid analogue Human mechanism – unclear, difficult to separate the toxicity of glyphosate from surfactants and other additives
Symptoms Treatment GI/caustic supportive Pulmonary (?aspiration) CV, renal, CNS toxicity 48
16 Pesticides
acetochlor amide propanil
Symptoms Treatment methemoglobinemia Methylene blue
49
Fungicides
Metallic/organo-metallic Ba, Cu, Cd, Sb, Hg Substituted Aromatics Chlorothalonil, pentachlorophenol, hexachlorobenzene Thiabendazoles Benomyl, terrazole, thiabendazole
50
Fungicides Dithiocarbamates
51
17 Pesticides
Fumigants
Phosphene – see rodenticides
Methyl bromide
Sulfuryl flouride
52
Fumigants Methyl Bromide
Heavier than air Chloropicrin additive Phased out (oxone-depleting agent)
Skin Treatment irritation, blistering supportive Pulmonary dyspnea, NCPE CNS visual disturbances, tremor, sz, coma 53
Fumigants Sulfuryl Fluoride (Vikane)
Heavier than air Chloropicrin Suspected flouride poisoning mechanism
Mucus membranes (skin, GI, resp) irritation, blistering Treatment CNS Supportive paresthesias, tremor, sz, coma monitor Ca CV Shock, cardiac dysrhythmias 54
18 Pesticides
Pesticides Others
Moth balls
DEET
Molluscicides
55
Others Moth Balls
Salt H2O XR Sx Tx water Camphor float float luc CNS/Sz support
faint metHb meth Napthalene sink float op Hemolysis blue Paradichloro N/V, HA, sink sink op support -benzene CNS
56
Others DEET
N,N-diethyl-3-methylbenzamide Wide safety margin
Primarily CNS toxicity Only after high doses
57
19 Pesticides
Others Molluscicides
quaternary ammonium compounds carbamates metals
Metaldehyde acetaldehyde? GI – N/V/D, abdominal pain CNS – seizures, coma, hyperthermia
58
Pesticides
Insecticides Fungicides
Rodenticides Fumigants
Herbicides Others
59
20 Terrorism / Hazmat
2012 ACMT Toxicology Board Review Course
Warfare, Terrorism and Other
J. Dave Barry Naval Medical Center Portsmouth Portsmouth VA
The Core Content of Medical Toxicology
Warfare, Terrorism and Other
Chemical Nuclear Biological Hazardous Materials
1 Terrorism / Hazmat
Chemical Agents
Nerve agents Blister agents Incapacitating agents Riot control agents Pulmonary agents Blood Agents (cyanogens)
Chemical Agents Nerve Agents History 1930’s – Nazi’s synthesize “G” agents during WWII Never used in battle Tested in concentration camps 1940’s – Soviet Union begins production after capturing German munitions 1950’s – US begins production 1990’s – Aum Shinrikyo Matsumoto ‘94, Tokyo ‘95 Iraq against Kurds
Chemical Agents Nerve Agents
Goldfrank’s Toxicologic Emergencies – 8th Ed (2006)
2 Terrorism / Hazmat
Sympathetic Parasympathetic (cholinergic)
agit N M Sz M C sec mio
N T sec rr ne
sec vasoconstr hr N hr ne L
mot N M S sec N Fasic paraly mict
Aging Half-Life >14h 3h 2-6 min 48h
Chemical Agents Nerve Agents
Personal Protection Respiratory Skin
Decontamination Alkaline solutions Diluted sodium hypochlorite soln Soap & water
3 Terrorism / Hazmat
Chemical Agents Nerve Agents
Treatment Atropine – combat excess muscarinic Ach Goal – dry respiratory secretions Diazepam – combat excess nicotinic Ach Oximes (Pralidoxime) – combat “aging”
Aging >14h 3h 2-6 min 48h Half-Time
Chemical Agents Nerve Agents
Pretreatment Pyridostigmine Carbamate (reversible) Protect a small % of AchE from irreversible OP aging
4 Terrorism / Hazmat
Chemical Agents Blister Agents
Mustards Sulfur Mustard (HD) Nitrogen Mustard (HN) Lewisite (L) Phosgene Oxime (CX)
Chemical Agents Blister Agents History 1917 WWI, Ypres 1930’s Italians vs. Ethiopia 1940’s WWII Japanese vs. Chinese German/Japanese concentration camps 1960’s Egypt vs. Yemen (alleged) 1980’s Iraq vs. Iran
High casualty rate, low mortality (>20:1)
Chemical Agents Blister Agents
Sulfur Liquid Pale Garlic, Hours Immediate Fluid 2 weeks – Mustard yellow to onion or later , but filled 3 years (HD dark mustard effects brown delayed til hours later
Lewisite Liquid Colorless Geranium immediate Seconds Fluid Days (L) to amber -like smell to minutes filled or black
Phosgene Solid colorless Irritating Immediate Seconds Solid 2 hours oxime or as solid, wheal (CX) liquid yellow- brown as liquid
5 Terrorism / Hazmat
Chemical Agents Mustard Mechanism Alkylating agent “Cyclization” reactive sulfonium ion Alkylates sulfhydryl (-SH) and amino (-NH2) groups
Depletes glutathione Increased oxidative stress
Chemical Agents Mustard Clinical Effects Vapor or liquid exposure Cellular damage w/i 1-2 min Clinical effects 2-48hrs (usually 4-8hrs) Skin Erythema vesicles blisters/bullae Eye Range: Mild severe conjunctivitis ‘legal’ blindness possible Airways Bronchospasm, pulmonary edema Obstruction, hemorrhage in severe cases
Chemical Agents Mustard Clinical Effects Skin Eye Airways GI N/V, GI bleed Systemic BM suppression/immunosuppression With high doses IARC Group I – respiratory cancer
6 Terrorism / Hazmat
Chemical Agents Mustard Diagnosis M8, M9 paper, etc Thiodiglycol Urine, blood
Treatment Decontamination Supportive/symptomatic care No antidote
Chemical Agents Mustard Decontamination Remove large globs or liquid Soap and water, diluted hypochlorite Military self decon kits
Chemical Agents Lewisite History less persistent alternative to mustard agents No confirmed battlefield use
Mechanism Unclear similar to other arsenicals? Inhibition of pyruvate dehydrogenase Inhibition of other lipoamide enzymes
7 Terrorism / Hazmat
Chemical Agents Lewisite Clinical Effects Immediate effects (unlike mustard) Similar to mustard Skin – erythema, vesicles, blisters Eyes - conjunctivitis Airways – MM irritation, pulmonary edema Treatment Same as mustard BAL (British Anti-Lewisite) (dimercaprol) Topical / systemic
Chemical Agents Phosgene Oxime Background No battlefield use Penetrates garments more quickly than other agents Rapid onset severe and prolonged effects
Mechanism Unclear Not a true vesicant Irritant or “nettle” agent
Chemical Agents Phosgene Oxime Clinical Effects Immediate severe tissue damage Skin – erythema, wheals, urticaria Eyes – conjunctivitis Airways – pulmonary edema Treatment Supportive No antidote
8 Terrorism / Hazmat
Chemical Agents Incapacitating Agents
US experimented with multiple agents
Antimuscarinics felt to be most promising BZ (3-quinuclidinyl benzilate) Physostigmine is potential antidote
Opioids Kolokol-1 (fentanyl analogue) 2002 Chechen Moscow Theatre Siege
Chemical Agents Riot Control Agents
CN (chloracetophenone) Mace® CS (o-chlorobenzilidene malenonitrile) Capsaicin (“pepper spray”)
Chloropicrin (trichloronitromethane) DM (adamsite)(vomiting agent)
Chemical Agents Riot Control Agents OC - Capsaicin (“pepper spray”) better safety margin / more potent Release of Substance P - “neurogenic inflammation” depletion
9 Terrorism / Hazmat
Chemical Agents Pulmonary Agents
Phosgene (CG) Diphosgene (DP) Chlorine (Cl)
Nitrogen Oxides (NOx) Perfluoroisobutylene (PFIB)
Chemical Agents Pulmonary Agents
Chlorine (Cl) Yellow-green Gas, with Strong bleach Intermediate Immediate pressure and irritation, cooling can be pulmonary liquid edema 2-24hrs later Phosgene Colorless or Gas, with Freshly mown Poor Delayed up to (CG) white to pale- pressure and hay, green corn 48hrs (usually yellow cloud cooling can be 2-6 hrs) liquid Diphosgene Colorless gas Freshly mown Poor Delayed up to (DP) hay, green corn 48hrs (usually 2-6 hrs)
Nuclear/Radiological
Atomic Radiation Primer Measurement Acute Radiation Syndrome/Dosimetry Treatment of Radiation Injuries Scenarios Specific Radionuclides
10 Terrorism / Hazmat
Nuclear/Radiological Atomic Radiation Primer
Nonionizing radiation Doesn’t have enough energy to disrupt atoms or molecules
Ionizing radiation Radiation with enough energy to disrupt an atom or molecule that it hits
Nuclear/Radiological Atomic Radiation Primer
Ionizing Radiation Effects DNA effects Repairable Damage Mutations Cell Death
Nuclear/Radiological Atomic Radiation Primer
Ionizing Radiation Effects DNA effects Repairable Damage Mutations Cell Death Free Radical Formation Hydroxyl free radicals
11 Terrorism / Hazmat
Nuclear/Radiological Atomic Radiation Primer
Ionizing Radiation Effects
Dose absorbed depends on: Time Distance (1/R2) Shielding
Nuclear/Radiological Atomic Radiation Primer
Nuclear/Radiological Measurement
Geiger Counter
Gamma Spectroscopy
12 Terrorism / Hazmat
Nuclear/Radiological Acute Radiation Syndrome
Nuclear/Radiological Acute Radiation Syndrome
0.7-10 Gy 70-1000 Rads
10-50 Gy 1000-5000 Rads
>50 Gy >5000 Rads
CXR – 0.25 mRem Abd CT – 5-60 mRem Whole body dose limit – 5 Rem/yr
Nuclear/Radiological Dosimetry
Nonspecific/GI symptoms (time to vomit) <0.7Gy (70Rads): no effects 1-2Gy (100-200Rads): vomiting in 50% w/i 6hrs
3Gy (300Rads): vomiting w/i 4hrs LD50/60 without medical care 8Gy (800Rads): early, severe vomiting
13 Terrorism / Hazmat
Nuclear/Radiological Dosimetry
Lymphocyte reduction Drop in lymphocytes q6hrs Dose rate of decline of lymphocytes
Nuclear/Radiological Dosimetry
Chromosomal cytogenetics # abberations dose
Nuclear/Radiological Treatment
Treat conventional (lifethreatening) injuries first!
Decontaminate (if necessary) External decon (remove clothes, decontaminate wounds first) Internal decon
Dosimetry screen Cbc w diff q6 Absolute lymphocyte count (ALC)
14 Terrorism / Hazmat
Nuclear/Radiological Treatment
Internal decontamination Antacid (decrease absorption) Precipitate to insoluble salt Saturate critical organ with stable isotope KI (I131) Chelation DTPA (239Pu), prussian blue (137Cs), BAL, etc. Catharsis (decrease residence time)
Nuclear/Radiological Treatment
Supportive care Antimicrobials, antiemetics, anxiolytics, antidiarrheals, fluids, electrolytes, analgesics, burn therapy, psychosocial care Surgical intervention in first 36hrs Stimulation of the hematopoetic system cytokines, colony stimulating factors
Nuclear/Radiological Sources/Scenarios
Simple Radiological Device RED: radiological emitting device Radiological Dispersal Device
Reactor Accident - ’meltdown’ (criticality) Improvised Nuclear Device Nuclear Weapon
15 Terrorism / Hazmat
Nuclear/Radiological Specific Radionuclides
Radioactive elements act the same in the body as regular elements, they just give off radiation.
131I Radon Depleted Uranium
Nuclear/Radiological Specific Radionuclides
Iodine (131I) T1/2 = 8.03 days, emits beta/gamma radiation Low levels in hospital nuclear medicine departments Nuclear reactor accidental releases / nuclear bombs
Accumulates in thyroid tissue if incorporated – thyroid damage
Prophylactic treatment with Potassium Iodide (KI)
Nuclear/Radiological Specific Radionuclides Radon (222Rn) Heaviest noble gas, alpha/gamma emissions Product of the natural decay of uranium in soil, concentrated indoors Largest component of background radiation
16 Terrorism / Hazmat
Nuclear/Radiological Specific Radionuclides
Radon (222Rn) incidence of lung cancer (IARC I) (EPA estimates 21,000 deaths/yr) Avoidance: enclosed space ventilation, detectors, don’t smoke
Nuclear/Radiological Specific Radionuclides Depleted Uranium (238U) Natural uranium is mixture of 235U (0.7%) and 238U (99.3%). Reactors and weapons require the more radioactive 235U
After enrichment, 238U is left 0.7 X as radioactive as natural uranium
T1/2 45billion years (very little decay) Alpha, beta, gamma emmitter
Nuclear/Radiological Specific Radionuclides Depleted Uranium (238U) Low risk radiation hazard internal contamination (inhalation) is controversial.
Primarily a chemical toxicity (renal toxicity)
17 Terrorism / Hazmat
Biological Warfare
Toxins Bacteria Viruses
Biological Warfare Toxins
Botulinum Toxins Ricin Staphylococcal Enterotoxin B (SEB) T-2 Mycotoxins
Biological Warfare Botulinum Toxins Produced by Clostridium Botulinum 7 antigenic types: A-G Military relevance Most potent toxins known Easily produced Weaponized by several countries Soviet Union, Iran, Iraq, North Korea, Syria 1960’s US – Agent X Terrorists – Aum Shinriky (1990-1995)
18 Terrorism / Hazmat
Biological Warfare Botulinum Toxins Inhibits Ach release at peripheral NMJ Heavy chain binds to cell membrane, endocytosis allows entry to cell Light chain cleaves specific sites of SNARE proteins, inhibiting exocytosis and Ach release Doesn’t cross BBB
JAMA. 2001;285:1059-1070
Biological Warfare Botulinum Toxins
Foodborne: toxin ingestion after production by bacteria in (canned) food Infant: intestinal colonization Wound: colonization Inhalational: weaponized agents
All have similar clinical picture: Progressive descending flaccid paralysis Always starts with cranial nerves/bulbar involvement
Biological Warfare Botulinum Toxins
Diagnosis Mouse neutralization assay ELISA Wound or stool Culture
JAMA. 2001;285:1059-1070
19 Terrorism / Hazmat
Biological Warfare Botulinum Toxins Treatment Supportive care Antitoxin (equine) Bivalent (A,B) Type E
Immune Globulins (BIG) BIG (BabyBIG)
Heptavalent (A-G) (dBIG)(Fab2 fragment)
Biological Warfare Botulinum Toxins
Vaccine Pentavalent (A-E) (IND)
Biological Warfare Ricin
Ricinus Communis (castor Bean) attractive as a biological weapon since it’s widely available, cheap and has a heat stable toxin History Compound W (WWII) Georgi Markov (1978)
20 Terrorism / Hazmat
Biological Warfare Ricin Mechanism Inhibits protein synthesis B Chain Binds to cell surface, undergoes endocytosis to enter cell A Chain Binds and inhibits 60S ribosome, inhibiting protein synthesis
Biological Warfare Ricin
Symptoms vary based on route of exposure In general: Local tissue irritation regional lymph node necrosis multi-organ failure PO N/V/D, vascular collapse, shock IM Local pain, regional painful swollen lymph nodes, multi- organ failure Inhalational Pulmonary edema, pneumonia, mediastinal lymphadenitis, multi-organ failure
Biological Warfare Ricin Diagnosis ELISA assay of nasal swab, blood or other fluids Treatment Supportive care AC may bind orally ingested toxin No antidote
Prophylaxis None, vaccine being investigated
21 Terrorism / Hazmat
Biological Warfare Staphylococcal Enterotoxin B
Military relevance potent compared to chemical agents Incapacitating (usually not lethal) Studied by US in 1960’s as a biological incapacitant (PG)
Biological Warfare Staphylococcal Enterotoxin B
“superantigens” Profound activation of the immune system Bind monocytes (MHC Class II molecules) - stimulation of helper T-cells - massive release of cytokines (interferon gamma, interleukin-6, TNF- ) - intense inflammatory response
Biological Warfare Staphylococcal Enterotoxin B GI Syndrome Identical to staph food poisoning Pulmonary Syndrome inhalation of weaponized toxin
22 Terrorism / Hazmat
Biological Warfare Bacteria
Anthrax Plague Tularemia Brucellosis Q Fever
Biological Warfare Anthrax Bacillus anthracis Gram +, capsulated, spore-forming bacillus Virulence factors Antiphagocytic capsule Lethal toxin Edema toxin
Biological Warfare Anthrax Virulence factors Antiphagocytic capsule No virulence without this capsule Lethal toxin Zinc metalloprotease Stimulates macrophages to release TNF and IL-6 Edema toxin Calmodulin-dependent adenylate cyclase cAMP leads to massive edema and impaired neutrophil function
23 Terrorism / Hazmat
Biological Warfare Anthrax General Pathophysiology Spores exist worldwide in the soil Spores enter the body, are ingested by macrophages and germinate Incubation period 1-6 days Bacteria multiply in local lymph nodes leading to: edema, hemorrhage tissue necrosis
Biological Warfare Anthrax
Cutaneous Inhalational GI
Biological Warfare Anthrax Cutaneous 95% of cases, 2000 annually worldwide Vesicle – painless necrotic ulcer – lymphadenitis – black eschar – scar Septicemia is rare.
24 Terrorism / Hazmat
Biological Warfare Anthrax Cutaneous Inhalational Woolsorters disease Aerosol release from Biological weapons Fever, malaise, myalgia, fatigue chest pain, respiratory distress cyanosis, shock, death Wide mediastinum Hemorrhagic meningitis is common Anticipated mortality essentially 100%
Biological Warfare Anthrax
Cutaneous Inhalational GI Rare, but high mortality 25-60% Ingestion of poorly cooked, contaminated meat N/V/D, abdominal pain ascites, hematemesis - toxemia, shock, death
Biological Warfare Anthrax
Med Sci Monit. 2003;9(11):RA276-283
25 Terrorism / Hazmat
Biological Warfare Anthrax Immunization Cell free vaccine attenuated, unencapsulated strain Main ingredient is ‘protective antigen’ FDA approved for “at risk” populations
Biological Warfare Anthrax Immunization Prophylaxis
Med Sci Monit. 2003;9(11):RA276-283
Biological Warfare Plague
Biologic Warfare History Crimean port city of Caffa 1346-1347 First attempt at biologic warfare
26 Terrorism / Hazmat
Biological Warfare Plague
Biologic Warfare History Crimean port city of Caffa 1346-1347 First attempt at biologic warfare WWII Japanese Unit 731 Suspected use against the Chinese
Biological Warfare Plague
Biologic Warfare History Crimean port city of Caffa 1346-1347 First attempt at biologic warfare WWII Japanese Unit 731 Suspected use against Chinese Soviet Union 1970’s-1980’s Reported to have genetically engineered, dry, antibiotic resistant form of plague
Biological Warfare Plague Yersinia pestis Gram -, nonsporulating, anaerobic bacillus More deaths than any other infectious agent in history Virulence Factors Antiphagocytic fraction, pH 6 antigen, Yop H, Yop E, Yop M, V antigen, plasminogen activator environmental signals within the host (pH, temp, etc) induce the synthesis and activity of these factors, contributing to virulence.
27 Terrorism / Hazmat
Biological Warfare Plague
Biological Warfare Plague General Pathophysiology Introduction by flea, ingestion or inhalation Initially susceptible to phagocytisis but induction and synthesis of virulence factors leads to resistance Spread to regional lymph nodes (1-8d incubation) Septicemia and multi-organ involvement if untreated
Biological Warfare Plague
Bubonic Pneumonic
28 Terrorism / Hazmat
Biological Warfare Plague Bubonic Bubo Painful lymphadenopathy (90% inguinal or femoral) Constitutional symptoms (F/C, HA, etc) 5-15% develop 2o pneumonic plague
Biological Warfare Plague Bubonic Pneumonic 1o: inhalation of aerosols human-human or weaponized 2o: hematogenous spread Productive cough with blood-tinged sputum Bilateral alveolar infiltrates
Biological Warfare Plague
JAMA. 2000; 283:2281-2290
29 Terrorism / Hazmat
Biological Warfare Plague
JAMA. 2000; 283:2281-2290
Biological Warfare Plague
Vaccination Killed whole cell vaccine Not effective against pneumonic plague
Other vaccine development underway
Biological Warfare Viruses
Smallpox Equine Encephalitis Viral Hemorrhagic Fevers (VHF)
30 Terrorism / Hazmat
Biological Warfare Smallpox
Variola a poxvirus large enveloped DNA virus Certified by WHO as eradicated in 1977
Military Relevance Infectious as aerosol Increasingly naive population (not immunized) Easy large scale production, stable virus
Biological Warfare Smallpox
Incubation – not contagious, 7-17 days
Prodrome – viral syndrome, 2-4 days
Rash – centrifugal, highly contagious Vesicular - pustular - umbilicated - scab Scabs form 10-14d after onset of rash Recovery – immunity not contagious once all scabs separate 14-28 d after rash onset
Smallpox Day 3 of Day 5 of Day 7 of Rash rash rash rash
Centrifugal Hands/face Synchronous All in same stage
Highly contagious by aerosol 30% mortality in unvaccinated population
31 Terrorism / Hazmat
Biological Warfare Smallpox Complications Bronchitis, pulmonary edema Arthritis, osteomyelitis Encephalitis Keratitis, corneal ulcer Infection in pregnancy High perinatal fatality
Biological Warfare Smallpox
Biological Warfare Smallpox Lab Diagnosis – virus isolation from pharyngeal swab or scab material (PCR, ELISA) Treatment Supportive care Isolation (and vaccination) of patient and all contacts for 17 days Vaccination (w/i 4 days) VIG (w/i 1 week) Cidofovir
32 Terrorism / Hazmat
Biological Warfare Smallpox Vaccination Vaccinia – a poxvirus related to cowpox Scarification with a bifurcated needle Contraindicated in: Immunosuppresed HIV Eczema other skin diseases Pregnancy Children < 18mo
Hazardous Materials
Treaties Incident Command System, Site Safety National Pharmaceutical Stockpile Regulatory/Legal Acts
end
Hazardous Materials Control Zones
Hot Zone WarmZone Cold Zone
33 Terrorism / Hazmat
flammability
health instability
special
Warfare, Terrorism and Other
Chemical Nuclear Biological Hazardous Materials
34 An microbials
An microbials
Michael Policastro, MD Director, Medical Toxicology, QESI Clinical Assistant Professor, WSU
Overview
• An microbials • An mycobacterials • An virals • Disinfectants • An fungals • An parasi cs • Adverse Effects by Systems
An bio cs
• Cell Wall (β- lactams, Glycopep des- Vanc) • Cell membrane (Polymyxin B) • Protein synthesis (Aminoglycosides,Tetracycline, Linezolid Macrolides, Chloramphenical) • Nucleic Acids (Fluoroquinolones, Metronidazole, Rifampin) • An -metabolites (Sulfonamides,Trimethoprim)
1 An microbials
Β-lactam
• Penicillins: - Anaphylaxsis, SZ ( Picrotoxin binding site GABA), ↑K – Hoigne Syndrome: males, fear/illusion, apprehension – Jarisch-Herxheimer: fever, chills, rash; lysed bacteria • Cephalosporins: nMTT side chain • ( moxalactam, cefazolin, cefoperazone, cefmetazole, cefmandole, cefotetan) • hypothrombinemia, Vit. K epoxide reductase inhibi on, • disulfiram rxn • Cefaclor = serum sickness • Imipenem: Seizures, Picrotoxin binding site • No PNC cross reac vity with Impenem, Aztreonam
Disulfiram reac ons
• Metronidazole • Cephalosporins with NMTT side chain: - cefoperazone, cefamandole, moxalactam, cefotetan, cefmetazole • Chloramphenical • Nitrofurantoin • Trimethoprim-sulfamethoxazole • Griseofulvin • OSHA: chlorpropamide, tolbutamide • Mushrooms: Coprinus,Clitocybe,Tricholoma
Clinical Environmental Health and Toxic Exposures .Sullivan and Kreiger.2001 . Table 18-4. P.238
Vancomycin
• Inhibits cell wall synthesis binding D-alanyl-D- alanine cell wall precursors • Tox: Red Man syndrome, ototoxicity, nephrotoxicity
2 An microbials
Aminoglycosides
• Inhibits 30s ribosomal subunit • Nephrotoxicity, Ototoxicity, Ve bulotoxicity • NMB: inhibit presynap c release of ACH
Chloramphenical
• Inhibits 50s ribosomal subunit • Metabolism: glucuronyl transferase • limited conjugate in children • “Grey baby”-vomi ng,anorexia, ash color, met acidosis • Aplas c anemia, peripheral neuropathy , op c neuri s , metabolic acidosis, cardiovascular collapse
Drugs that undergo primary Synthe c Phase II Biotransforma on that you may forget
• Glucuronida on : Valproic acid, lamotrigine, opioids, APAP, irinotecan, 5-FU, chloramphenical
• Acetyla on: INH, hydrazines, Sulfonamide, Dapsone, amonafidine
3 An microbials
Macrolides/Ketolides/Licosamides
• Inhibit 50s ribosomal subunit • Eythromycin,azithromycin,clarithromycin, Clindamycin • Inhibit 3A4 except azithromycin, ↑QT • Inhibit PGP intes nal = Digoxin • Chronic cholesta c hepa s, sensory neural hearing loss • Telithromycin: carbamate side chain; cholinergic crisis in Myasthenia pts • Clindamycin: C.diff, Stevens-Johnson, NMB, dysrhythmias
Tetracycline
• Inhibits 30s/50s ribosomal subunit • Teratogen- Teeth discolora on, hypoplas c enamel, seen a er 4th month • Benign intracranial hypertension • Phototoxicity, pneumoni s, drug-induced Lupus • Minocycline: Lupus like syndrome, Diabetes Insipidus ( DI) • Democycline: nephrogenic DI
Linezolid
• Inhibits N-formylmethionyl- tRNA • HA, thrombocytopenia • Brown discolora on tongue • Weak MAO inhibitor • Serotonin syndrome with SSRIs
4 An microbials
Nitrofurantoin
• Pulmonary: dyspnea/cough, inters al fibrosis • Rash, Lupus like syndrome • Neuropathy peripheral • Disulfiram reac ons
Fluoroquinolones
• Inhibit DNA gyrase/topoisomerase • Binds Ca ons, esp. Mg2+ • Seizures: Binds Mg2+, + NMDA, (-) GABA • QTc= sequestra on Mg2+ • Car lage/Tendon damage • Hepatoxicty • Psychosis, serum sickness
Metronidazole
• Metallic taste • Peripheral neuropathy • Disulfiram reac on
5 An microbials
Sulfonamides
• Inhibit para-amino acid/para-amino acid glutamic acid • Folate synthesis inhibitor • Hypersensi vity Rxns • MetHgb, hemolysis • Pneumoni s, hepatotoxicity- cholestasis, asep c menigi s
Folate Inhibitors- An metabolites
• MTX • Sulfasalazine • Proguanil • Aminopterin • Pyrimethane • 5-FU • Dapsone • Atovaquone • Sulfonamides • Trimethoprim • Triamterene
An mycobacterials- TB Drugs
• INH • Rifampin • Ethambutol • Pyrazinamide – nico namide analog, hepa s, gout • Cycloserine • Para-Aminosalicylic acid- hepa s, hypersensi vity reac on, thrombocytopenia • Capreomycin
6 An microbials
INH
• OD: Seizures, coma, metabolic acidosis • INH Tox : op c neuri s, pancrea s, hepa s • TOX: +/-slow acetylators, 2E1 • TX: Pyridoxone
Goldfrank’s Toxicologic Emergencies. 6th edi on. 2006. Figure 55-3 p.863
B6 ( Pyridoxine)
• Tx: hydrazines, ethylene glycol • Dose: INH- gram/gram • OD: sensory neuronal neuropathy, ataxia
Hydrazines
• INH • Non-selec ve MAO A/B Inhibitors: -Phenelzine, Isocarboxazid, Procarbazine • Hydrazine ( Diamine) • Monomethyhydrazine • Gyromitra • Ginkgo Biloba seeds ( 4-Methoxypyridoxine)
7 An microbials
Rifampin
• Binds B units DNA dependent RNA polymerase • * 3A4 inducer • Red/orange body fluids • False nega ve PPD • TOX: hepa s, Lupus like syndrome, ARF, thrombocytopenia, hemoly c anemia, eosinophilic coli s
Ethambutol
• 1st line in pregnancy • Chelates metal • ** Zn chela on = op c neuri s • ** shi wavelength discrimina on • ** loss red/green discrimina on
Cycloserine
• Analog of alanine • Neuro dysfunc on • Sz, psychosis • Contraindicated in Seizure Pa ents • Safe in breast feeding
8 An microbials
Capreomycin
• * Hearing loss, nnitus • Preo nuria, electrolyte loss • Sterile abscess at injec on sites
An malarial
• Quinine • Chloroquine/Hydroxychloroquine/Amodiaquine • Primaquine- MetHgb, Contraindicated Pregnancy • Mefloquine: Neuropysch- Sz, psychosis • Proguanil/Pyimethamine/Suldoxine • Atovaquone • Dapsone • Artemisinin: very safe, sz
Chloroquine Quinine • Cardiac: Class Ia effect, neg • Cinchoa tree ( Rubiacea) ionotropy, VT, VF • Cinchoism: auditory, GI, swea ng, HA, vasodila on • Hypokalemia • Cardiac: Class Ia affect, • Sz, transient blindness myocardial depression, phase 0 • TX: AC, Hypokalemia depression, vasodila on protec ve Do NOT treat • Heme: thrombocytopenia, aggressive, diazepam pupura, hemolysis • CNS: Blindness, Tinnitus/ deafness • Hypoglycemia- sulfonyurea like • TX: MDAC, Bicarb, ?Octreo de
9 An microbials
An malarials:Folate Inhibitors
• Atovaquone: Rash, erythema mul formae • Proguanil: GI, megaloblas c anemia, rash • Pyrimethamine: N/V, SZ, megaloblas c anemia • Dapsone
Dapsone
• Bacteriosta c synthe c sulfone, inhibits folic acid synthesis, binds dihydropterate synthase • Oxidizer, MetHgb, Hemolysis, also Sul emoglobin • “Sulfone Syndrome” delayed hypersensi vity syndrome = fever, eosinophilic pneumonia, derma s, hepa c necrosis • Also: thrombocytopenia, neutropenia, neuropathy • TX: MDAC, Methylene Blue, Exchange transfusion
HIV Drugs
Nucleoside Reverse Non-Nucleoside Reverse Nucleo de Analogue Transcriptase Inhibitors (NRTI) Transcriptase Inhibitors tenofovir DF/Viread (TDF) zidovudine/Retrovir (AZT, ZDV) (Non- NRTI ) Adefovir/Hepsera didanosine/Videx, Videx EC (ddI) nevirapine/Viramune Emtricitabine/Emtriva zalcitabine/HIVID (ddC) delavirdine/Rescriptor stavudine/Zerit (d4T) efavirenz/Sus va lamivudine/Epivir (3TC) Fusion (entry) inhibitors abacavir/Ziagen (ABC) Protease Inhibitors (PI) Enfuvir de/ Fuzeon indinavir/Crixivan ritonavir/Norvir saquinavir/Invirase,Fortovase nelfinavir/Viracept amprenavir/Agenerase lopinavir/ritonavir, Kaletra Atazanavir/Reyataz
10 An microbials
HIV Drug Toxici es
NRTI • Protease Inhibitors -lac c acidosis, impaired -Dyslipidemias, Hyperglycemia β –oxida on *ritanovir- hepatotoxicity, PGP TX: L-carni ne inhibitor -peripheral neuropathy *Indinavir-nephrolithiasis -Lipodystrophy syndrome
NNRTI - Skin rashes ( Stevens- Johnson, TEN, Eosinophilic systemic) * nevirapine - Hepatotoxicity, pancrea s - * Efavirenz- neurotox
Side effects of an retroviral medica ons Side Effect Drugs
Lactic acidosis Nucleoside reverse transcriptase inhibitors, especially didanosine, stavudine
Hypersensitivity reaction Abacavir, nevirapine
Liver toxicity Saquinavir, ritonavir, nelfinavir, tenofovir, nevirapine, efavirenz, atazanavir
Pancreatitis Didanosine, stavudine, zalcitabine, lopinavir/ritonavir
Nephrolithiasis Indinavir
Acute tubular necrosis Tenofovir
Acute interstitial Indinavir, ritonavir nephritis
Myelosuppression Zidovudine
Myopathy Zidovudine
Neuropathy Stavudine, didanosine, zalcitabine
An Virals
• Fusion Inhibitors- • M2 protein Blockers Guanosine Analogs - Amantadine, Rimantadine -Acyclovir • Neurominidase Inhibtors -Famciclovir -Oseltamivir -Ganciclovir • Other -Valacyclovir - Ribavirin -Valganciclovir - Cidofovir • Pyrofosfate Analog - Palivizumab - Foscarnet
11 An microbials
An virals
• Amantadine: pre-synap c DA blockade; TOX: Hyperthermia,↑QT, ? An cholinergic • Oseltamivir: GI • Acyclovir: Neurotox/Nephrotox- crystal forma on • Ganciclovir: Re nal tox • Valacyclovir: TTP • Foscarnet: *chelates divalet metals: Ca, Mg, Fe, Zn, Nephrotox • Cidofovir: Nephrotox, OD TX: * Probenicid decreases renal clearance/renal failure • Ribavirin: teratogen,sperm morphology
An sep cs, Disinfectants, Sterilants
• An sep c: Agent applied to living ssue to kill/ inhibit microorganism
• Disinfectant: Agent applied to inanimate objects to kill microorganisms.
• Sterilant : Agent applied to inanimate objects to kill all microorganisms and spores
Disinfectants
• Formalin: 37 % Formaldehyde + 15 % methanol, Formaldehyde IARC 1 classifica on
• Phenol ( carbolic acid ) : severe burns skin /oral white ulcers, sz, met acidosis, rabbit syndrome (↓DA) -TX: PEG ,Isoproponal – skin burns
• Benzalkonium chloride: quarternary ammonium- occasional paralysis, NMJ- ACHE inhibi on, occ. asthma
12 An microbials
An sep cs
• Chlorhexidine: vaporized converts p-chloraniline, MetHgb
• Hydrogen peroxide: Conc. dependent, possible air emboli, local injury
- • Iodophors: (I2 ) elemental iodine, (I ) iodide: inges on, blue- purple emesis with starch, false posi ve Hematest (orthotoluidine), caus c, GI bleed psuedohyperchloremia. TX: Covert Iodine to Iodide with milk/starches, thiosulfate
• Potassium Permanganate: oxidizer, reacts with H20 to form manganese dioxide ( stains areas brown-black), potassium hydroxide and molecular oxygen. -Acute : local injury, MetHGB. - Chronic: possible Manganese poisoning- ams, parkinsonism, behavior d/o. -TX: Skin stains- dilute oxalic acids, NAC
Sterilants
• Ethylene Oxide: spontaneous abor ons,Oligiospermia mutagenic, Possible carcinogenic- leukemia, gastric CA, motor/ sensory neuropathies • Glutaraldehyde: vapor- cp, palpita ons, mucosal irritant
An fungals
• Amphotericin • Imidazoles -Liposome B complex to reduce ( ketaconazole, clotrimazole, econazole, nephrotox miconazole) -Inhibit fungal cell walls -Nephrotox • 3A4 Inhibitors, ↑QT with -Fever, chills due to PGE2 disrup on terfenadine,cisapride,astemizole -↓ K, Mg, WBC, Plts • Ketoconazole: Alopecia, gynecomas a, adrenal suppression, - Tinnitus androgen suppression, hepa s
• Triazole (fluconazole, itraconazole, terconazole, voriconazole) -Inhibits ergosterol synthesis, ↑LFTs - Inhibits * 3A4
13 An microbials
An helmin cs
• Mebenazole: teratogenic,rash • Thiabendazole: GI, cholestasis,leukopenia,Hypersensi vity rxn • Levamisole: ↓Plts, encephalopathy, TEN • Niridazole: Sz • Piperazine: Angioedema, sz • Metrofonate: inhibits ACHE, cholinergic crisis • Hyocanthone:mutagenic, carcinogenic • Ivermec n: Facial edema, bullous skin • Suramin: Renal/adrenal insufficency, TEN • An mony ( 3+/5+): GI, derma s; TX:BAL
Neurologic Adverse effects
• AMS: Ethambutol, PNC, Chloramphenical, Mefloquine, Efavirenz • Intracranial Hypertension: Tetracyclines, Albendazole • Seizures: PNC, Cephalosporins, Rifampin, Sulfonamides, Fluoroquinolones, INH, Ethylene oxide, Imipenim • Neuromuscular blockade: Polymyxin B, Fluoroquinolones,colis methate Aminoglycosides, Clindamycin, Vancomycin, Benzalkonium chloride • Myosi s: Chloroquine, PNC, Rifampin, Sulfonamides, Zidovudine • Peripheral Neuropathy: Chloramphenical, Flagyl, Ritanovir, Didanosine, Zalcitabine,Stavuidine, amprenavir • Movement Disorder: Potassium Permanganate, Phenol • Ototoxicity: Vancomycin, Chloroquine/Quinine, Aminoglycosides, erythromycin • Op c neuri s: Ethambutol, Chloramphenical, Cidofovir, Gancyclovir • Re nal Blindness: Quinine, Hydroxychloroquine
Skin Rash Adverse Effects
• “Red Man”- Vancomycin • “Grey baby”- Chloramphenical • Blue ( MetHgb): Sulfonamides,Dapsone, Primaquine, chloroquine, nitrofurans, • Stevens-Johnson: PNC, Cephalosporins, Sulfa, nevirapine • TEN: PNC, Sulfas, nevirapine • Vesiculobullous: PNC, Rifampin, Sulfonamides, Griseofulvin • Vasculi s: Levamisole • Acute Hypersensi vity Syndrome: Sulfas, Bacitracin, Clindamycin, Lincomycin, Nitrofurazone, nevirapine • Alopecia: Selenium Sulfide
14 An microbials
Renal/GU Adverse Effects
• Acute Tubular Necrosis: Aminoglycosides, Acyclovir, Amphotericin,Pentamidine, Polymyxins, Fluroquinolones,Foscarnet, Ritonavir, Tenovir, Phenazopyridine • Acute Inters al Nephri s: PNC,Ampicillin,Rifampin,Sulfonamides, Vancomycin • Nephrolithiasis/Obstruc on: Indanavir, Sulfonamides ( crystal deposits), Acyclovir • Tubular dysfunc on: Aminoglycosides, Amphotericin, Tetracycline, Griseofulvin • Decrease Sperm: Ethylene oxide , Nitrofurantoin, Ribavirin • Abor ons: Ethylene Oxide
Electrolyte Adverse Effects
• Diabetes Insipidus: Amphotericin, Foscarnet, Minocycline, Rifampin, Streptozotocin • Hypokalemia ( ↑ QT): Aminoglycosides, Amphotericin, Chloroquine • Hyperkalemia: PNC, Triamterene, Trimethoprim • Hypocalcemia (↑QT): Aminoglycosides, Neomycin • Hypomagnesium ( ↑QT): Aminoglycosides, Foscarnet, Fluroquinolones
Teratogens
• Fluconazole: Abnormal facies, cardiac, femoral bowing • Quinine: Hypoplasia 8th CN • Streptomycin: Hearing loss • Tetracycline: Teeth discolora on, hypoplas c enamel, seen a er 4th month • Trimethoprim: NTD, hypospadias • *See Folate inhibitor list*
15 An microbials
Hematologic/Immune
• Type I: IgE: PNC, tetracyclines, Sulfonamides, Nitrofurantoin,Streptomycin • Type II: An body IgG/IgM- cytopenias: Amoxicillin, Sulfonamide • Type III: Immune Complex IgG/IGM- Serum Sickness: Cefaclor • Type IV: T- lympocyte- contact derma s: Topical PNC • Oxida ve Hemolysis/MetHgb: Dapsone, Nitrofurantoin, Phenol, Sulfonamides, Novobiocin • Agranulocytosis: B-lactams, Cephalosporins, Chloramphenical, Dapsone, Ganicyclovir, Rifampicin, Sulfonamides, Vancomycin • Thrombocytopenia: Amphotericin, Indinavir, Levamisole, Quinine, Rifampin, Trimethoprim-sulfamethoxazole, Vancomycin • TTP: Valacyclovir
16 GI / HEME
Gastrointes nal/Hematologic Toxicology Board Review
Michael Policastro, MD Director, Medical Toxicology, QESI Clinical Assistant Professor, WSU
1
Overview
GI Heme • Oral/Anal • An platelet • Hepa c • An coagulants • Pancreas • Procoagulants • An mo lity • Thromboly c • Inflammatory Bowel Meds • Iron • An ulcer • Erythropoie n • Promo lity
2
Oral Discolora on
Tongue • Brown • Bromine, bismuth, arsenic, phenolpthalein, doxrubicin, quinacrine, tobacco • Green • Vanadium
• Black, Hairy • Cefoxi n, cor costeroids,lansoprazole, penicillin, sodium perborate, sodium • White peroxide, tetracycline • Chlorhexidine, phenol, caus c acids, hydrogen peroxide • Blue • Methylene blue • Blue Gray Gums • Bismuth, lead, mercury, copper salts, thallium, zinc
3
1 GI / HEME
Fecal Discolora on
• Acetazolamide, aluminum hydroxide, • Black aminophylline,amphotericin b,barium, benzene,bismuth, bromides, charcoal,chloramphenical,chlorpropamide,clindamycin,c or costeroids,cyclophosphamide,digitalis,feroous salts,fluoruracil,formaldehyde,halides,halothane, metals (Ag,As, Cu,Hg,Mn,Pb,Tl),hydralazine,methotrexetae,methylene blue, nitrates,NSAIDs, tetracycline,theophylline,warfarin
• Blue • Boric acid, chloramphenical, maganese dioxide, methylene blue • Yellow-green • Mercurous chloride, yellow phosphorus • Orange-red • Phenazopyridine, rifampin • Pink • Manganese dioxide, phenolthalein
4
Secre ons and Muscarinic Receptors
• M 1,3,5 = Phospholipase C • M2,4 = Adenylate cyclase • M3 = sphincter of oddi, ciliary body • M4 =agonism =Clozapine sialorrhea • Also unusual drooling: Aminopyridine ( CCB treatment)
5
Selec ve IgA deficiency- Drug Associated
• Captopril • Penacillamine • phenytoin
6
2 GI / HEME
Drugs that undergo primary Synthe c Phase II Biotransforma on that you may forget
• Glucuronida on : Valproic acid, lamotrigine, opioids, APAP, irinotecan, 5-FU, chloramphenical
• Acetyla on: INH, hydrazines, Sulfonamide, Dapsone, amonafidine
7
Hepatotoxin Classifica on Scheme
Clinical Environmental Health and Toxic Exposures .Sullivan and Kreiger.2001 .Figure18.3.pg 236. 8
Hepa c Toxophysiology
• Ingested toxins: enter via portal blood • Inhaled,dermal: enter via hepa c artery Zone 1 (periportal): highest O2,highest glycogen, highest mitochondria concentra on, Krebs cycle, more protein synthesis Zone 2 (intermediate)
Zone 3 (Centrilobar or peripheral): Lowest O2 tension, Glycogen storage, fat forma on, Cyp 450
Clinical Environmental Health and Toxic Exposures.Sullivan and Kreiger.2001.Figure18.1.pg 234. 9
3 GI / HEME
Zonal hepatotoxicity
• Zone 1 (periportal): Phosphorus, Iron, Allyl formate, P. Vulgarus endotoxin
• Zone 2 (intermediate or midzonal): Beryllium, Ngaione
• Zone 3 (Centrilobar or peripheral): Bromobenzene, halothane carbon tetrachloride, ethanol, APAP, paraquat,chlorinated hydrocarbons - *Think 2E1 metabolites *
10
Steatosis
• Macrovesicular: Nucleus displace by intracellular fat accumula on - Ethanol, Amiodarone - Amiodarone has lamellated intralysomal phospholipid inclusion bodies, ethanol doesn’t • Microvesicular: No nuclear displacement by fat; *failed β oxida on, more severe
11
Microvesicular steatosis
• Tetracycline • Margosa oil • VPA • Nucleoside inhibitors • Hypoglycin • Cerulide • Aflatoxin
12
4 GI / HEME
Hepa c Veno-Oclussive Disease
• Radia on, An neoplas cs ( Cyclophophamide) • Pyrrolinizide alkaloid plants -Symphytum species (Comfrey tea) - Heliotropium, Senecio (Ragwart) -Crotalaria ( Bush teas)
13
Buzzword Hepa s
• Peliosis Hepa s: Sinusoidal dila on, large blood filled cavi es : Androgenic Steroids • Vitamin A Toxicity :Increased fat content of sinusoidal Ito cells with increased collagen forma on
14
Xenobio c Autoimmune Liver injury
• Covalent binding of reac ve electrophile with hepatocellular protein creates an Adduct • APAP, minocycline, halothane, dihydrazine, phenytoin, germander
15
5 GI / HEME
Toxin-Hepa s Immunomarkers
• Halothane : an -trifluoroacetylated proteins • Iproniaziad : an -mitochiondrial type 6 autoan body ( an -M6) • Tienilic acid: An -liver kidney type 2 autoan body (an -LKM2) autoan body • Dihydralazine: an liver microsomal assay • Immunoallergic drug hepa s: Lymphocyte prolifera on assay
16
Drug Hypersensi vity Hepa s
• Halothane hepa s • trimethoprim-sulfamethazole • An convulsants • Allopurinol
17
Drug induced Cholestasis Without Hepa s • Estrogens/OCPs • Anabolic Steroids • Cyclosporin • 4,4’-methylenedianiline ( Epping Jaundice) • Rapeseed oil aniline ( Spanish toxic oil syndrome) • Alpha-napthyl-isothiocyanate ( ANIT) –acute cholangi s with PMN infiltra on
18
6 GI / HEME
Drug Hypersensi vity Cholestasis
• Chlorpromazine • Erythromycin • Penicillin • Rifampin • Sulfonamides
19
Occupa onal chemical cholestasis
• Toleune diisocyanate • Methylenediamine • paraquat
20
Hepa c Tumors
• Angiosarcoma: Vinyl chloride (chlorethane), arsenic, copper sulfate, Thoratrast, cadmium ? • Adenoma: Oral contracep ves ( OCP), androgens • Carcinoma: OCP, anabolic steroids, thoratrast, anabolic steroids • Hepatocellular carcinoma: aflatoxin, dimethylnitrosamine, ethanol • Focal Nodular Hyperplasia: OCP • Peritoneal Mesothelioma: asebetos amphibole fibers, eronite, thoratrast,
21
7 GI / HEME
Liver Carcinogens
• Aflatoxin ( Aspergillus flavus/parasi cus) • Mycotoxins • Pyrrolizidine alkaloids • Nitrosamides,Nitrosamines • Heterocyclic aroma c amines • Ethanol • OCP • Androgens, anabolic steroids • Azo dyes • Thoratrast- alpha radia on
22
Retroperitoneal fibrosis
• Methylsergide • Stephania tetrandra • Magnolia officinalis • Bromocrip ne • LSD
23
Exocrine Pancrea s
24
8 GI / HEME
Exocrine Pancrea s
* Tityus trinita s
25
Xenobio c Endocrine Pancrea s
• Alpha: Cobalt, biguanide,diguanide • Beta: Aflatoxin, Androgens, cyclizine,Cyproheptadine,Diazoxide,Glucagon, Epinephrine, Growth Hormone,Pentamidine, Streptozocin,sulfonamides, Vacor, Zinc Chelators
26
Pancrelipase ( Pancrease)
• Indica on: malabsorp on syndrome • Chronic use in Cys c Fibrosis * Fibrosing Colonopathy: abd pain, distension, cons pa ons
27
9 GI / HEME
An diarrheal Agents
• An Mo lity:Opioids: Diphenoxylate, Loperamide, Paregoric/Laudanum • Intraluminal Agents: Silicates, Bulk-forming fibers, Microfloral altering agents • An secretory : Somatosta n, Octreo de
28
Diphenoxylate
• Derived from meperidine • Metabolite: diphenoxylic acid ( 5x more ac ve, 2x ½ life) • Combined with atropine =Lomo l Meperidine • Onset: 4.5 hrs ( 1- 8 hrs) • Toxicity: delayed opioid
29
Loperamide
• Derived from diphenoxylate • 40 % absorp on, <1% absorp on • Poor CNS penetra on, • Rare respiratory • Large safety profile
30
10 GI / HEME
Opioids
• Paregoric • Laudanum • Camphorated ncture of • Deodorized Tincture of opium opium • Morphine (0.4 mg/ml) • Morphine (10 mg/ml) • Other components: • Use in Neonatal Abs nence essen al oil, Benzoic Acid, Syndrome /Neonatal Ethanol ( 45 %), glycerol Withdraw syndrome
31
Inflammatory Bowel Meds
• Mesalamine, Sulfasalazine • Immunomodulators ( Azathioprine,6-MP, infliximab) • Steroids • An bio cs
32
Mesalamine
• Salicylate based • Metabolism: acetyla on = n-acetyl- 5-ASA • Topical bowel an -inflammatory • AE: HA/Diarrhea • OD: low likelyhood salicylate toxicity
33
11 GI / HEME
Sulfasalazine
• Sulfa + salicylate ( 5-ASA) • Colonic bacteria split sulfa to free 5-ASA • 5-ASA Not absorbed in colon • AE: due to sulfapyridine *** decreased fer lity, abnormal sperm *** folate inhibitor Other AE: HA,n/v/d, rashes
34
Azathioprine and 6-MP
6-thioguanine (6-TG)
hypoxanthine–guanine phosphoribosyltransferase
thiopurine S- methyltransferase thiopurine S- xanthine methyltransferase oxidase
Nature Reviews Cancer 8, 24-36 (January 2008) 35
Azathioprine/6MP Adverse effects • Infec on • Myelosuppression, Leukemia • GI: diarrhea,mucosi s • Pregnancy D, NOT OK in Breas eeding • congenital anomalies: including polydactyly, plagiocephaly, congenital heart disease, hypospadias, and bilateral talipes equinovarus have occurred. • Monitoring: CBC and Thiopurine methyltransferase (TPMT) ac vity
36
12 GI / HEME
An ulcer
• Antacids • H2 blockers • Proton pump inhibitors • Misoprostol
37
Antacids
• Salts of: aluminum,magnesium,calcium, sodium hydroxide • Increase gastric pH • Toxicity with renal failure • Al = “dilaysis demen a”, encephalopathy, cons pa on • Mg =diarrhea, weakness, ↓Hr,reflexes,BP • Milk-Alkali (headache, occasional nausea and vomi ng, muscle ache, weakness and malaise) ( stones, bones, moans, groans) – seen with both calcium, sodium binders + milk/vitamin D − Hypercalcemia with suppressed PTH
38
H2 Blockers
• Cime dine, rani dine, famo dine, roxa dine, niza dine,e n dine • Inhibitors: 3A4, 2D6, 1A2, 2C9, 2E1 • AE: AMS, fa gue, possible thrombocytopenia, vasculi s, movement disorders • Cime dine: An androgen ( Gynecomas a ) • Rani dine: hepa s
Cime dine
39
13 GI / HEME
Proton pump inhibitors
• Rabeprazole,Lansoprazole,Omeprazole,Esmeprazole Pantoprazole • Block the gastric acid pump, H+/K+ (ATPase) • interac on 2C19, 3A4 • Alkali stomach may alter absorp on: griseofulvin, ketaconazole, iron • AE: diarrhea
40
Misprostol
• PGE1 antagonist (↓acid, ↑uterine contrac on, mucous,bicarbonate, dilate blood vessels ) • Pregnancy X • AE: abor facient, HA, diarrhea
41
Laxa ves
[Epsom Salts]
phenolphthalein
42
14 GI / HEME
Laxa ve Overdose
ACUTE CHRONIC • Osmo c: • Osmo c: -Magnesium: CNS, + aldosterone = hypoK respiratory↓ - Cathar c colon = -Phosphate: atrophy,atony hypocalcemia,QT↑ • S mulant • S mulant -psuedomembranosis -Phenolthalein: pulm edema, coli=macrophage pigment shock, met acidosis uptake,melanosis coli, harmless * Phenolpthalein = carcinogen, fixed drug erup on
43
Prokine cs
• Metoclopramide: 5HT3 antagonist, DA antagonist; AE: EPS, NMS, * MetHgb, neutropenia • Cisapride: 5HT4 agonist, 3A4 inhibitor, Ikr blockade, QT ↑ • Tegasarod (Zelnorm): par al 5HT4 agonist, 5HT1B agonist =↑vasoconstric on, MI, CVA
44
Hemostasis Pediatric Emergency Medicine Reports V14 N3 March 2009
45
15 GI / HEME
An platelets
Pharmacology Corner Flavio Guzmán, M.D. on 9/24/09 46
ADP Inhibitors
Ticlopidine Clopidogrel • 3-5 days onset • 2 hrs onset • 2C19 • 2C19, 3A, B6 and CYP1A2 • AE: rash, neutropenia, TTP • SS: 3-7 days • Severe OD: reversal with • AE: bleeding, rash platelet transfusion • 1 case report of HSP, TTP • Severe OD: reversal with platelet transfusion
47
Drug Induced Thrombocytopenia
48
16 GI / HEME
Occupa onal Isolated Toxic Thrombocytopenia • Immune: Toluene diisocyanate • Megakaryocyte hypoplasia: Dieldrin,Pyrethrin, Lindane,DDT
49
50
Indirect Thrombin Inhibitors
• Heparin: UFH ,LMWH (3,000-30,000 daltons) • Factor XA Inhibitors: Indirect/Direct • Vitamin K antagonist: Warfarin
51
17 GI / HEME
Heparin
Increased ATIII-thrombin (IIA) Rx 100-1000 fold
Thrombin
Most sensi ve to inhibi on of ATIII/Heparin complex 52
Protamine Sulfate
• Derived male salmon gonads • Binds heparin, ↓interac on with AT III • 1mg/unit heparin • Heparin rebound • Contraindica on: Allergy ( DM with AB due to protamine containing insulin)
53
Heparin Induced Thrombocytopenia
• Type I =Platelets ↓ • Type II = An platelet IgG an bodies Platelet 4 protein, paradoxical thrombosis, thrombocytopenia, 1 wk a er RX • Primarily UFH, possible but less likely with LMWH • All UFH/LMWH contraindicated in future,must use direct thrombin
54
18 GI / HEME
LMWH
Choices Mechanism • Ardeparin (Normiflo): • An thrombin III mediated • Daltaparen (Fragmin): Selec ve inhibi on Xa and to a • Enoxaparen (Lovenox): lesser extent IIa • Tinzoparin (Innohep):
55
56
Factor XA Inhibitors
• Fondaparinux ( Arixtra): Indirect, synthe c pentasaccharide, selec ve Factor Xa inhibitor • Rivaroxaban (Xarelto):Direct,oral,Selec ve factor Xa inhibitor • Apaxiban ( Eliquis):Direct, oral, Selec ve factor Xa Inhibitor
57
19 GI / HEME
Warfarin
Vitamin K(H2) Quinol Reduced Vitamin K epoxide reductase C1 (Ac ve)
Mayo Clinic Proceedings July 2010 85 (10) 58
Warfarin
Ac ve Inac ve
Reduced
59
Warfarin Skin Necrosis
Skin necrosis • 0.01-0.1 % of pts • Female> male • High fat area • Rapid protein C loss
60
20 GI / HEME
Fetal Warfarin Syndrome
• Pregnancy X • Crosses placenta • Nasal/midface hypoplasia • Bone s ppling of epiphyses on plain x- ray (chrondrodysplasia punc ) • Op c atrophy • Metal retarda on
61
Warfarin purple toe syndrome
• 3- 8 wks of therapy • Cholesterol microemboli
62
Vitamin K1 (Phytonadione)
• ½ life : 2 hrs • Oral:mephyton • IV: AquaMephyton • IV: only if lifethreat • ( < 1mg/min) • AE: photosensa vity, anaphylaxsis
63
21 GI / HEME
64
65
Direct Thrombin Inhibitors
• Hirudin( Refludan): Bivalent : Exosite 1, ac ve site binding • Bivalirudin: ( Angiomax,Hirulog):Bivalent: Exosite 1, ac ve site dinding • Argatroban: Univalent: Ac ve Site Only binding, N2-deriva ve of arginine • Dabigatran( Pradaxa): Univalent: Ac ve Site ONLY binding
66
22 GI / HEME
67
Thromboly cs
Thrombin specific fibrinolysis Non specific fibrinolysis • Alteplase • Streptokinase • Reteplase • urokinase • tenectaplase Side effect: -Allergy rxn if re-exposure
68
Aminocaproic Acid
• Reversal of fibrinoly cs • analogue of the amino acid lysine • Inhibits plasminogen ac vators • Renal elimina on • AE: hypotension,rhabdomyolysis
69
23 GI / HEME
Iron
Ionic Nonionic- low toxicity • Ferrous gluconate 12 % • Iron polysaccaride 46% • Ferrous lactate 19% • Carbonyl iron 98 % • Ferrous sulfate 20 % • Ferrous chloride 28 % • Ferrous fumarate 33%
70
Iron
• Fe 2+ (Ferrous) absorbed in duod/jejun, bound to Ferri n • Changed to Fe 3+ (ferric), bound to transferrin • Free iron ( Fe 3+) released • 4-5 Stages: GI,Latent,Shock/Met Acidosis,Hepa c failure,Gut Stricture
71
Iron
• >60mg/kg elemental iron ( Be able to calculate) likely tox • 4 hr serum Fe level >500mcg/dl + symptoms • Obtain radiographs • NOT Useful: WBC >15 K,Glc>150mg/dl,TIBC • Pregancy: ? placental receptor mediated endocytosis • Deferoxamine therapy
72
24 GI / HEME
Deferoxamine
• Derived from streptomyces pilosus • Indica ons: serum Fe>350-500mcg/dl, symptoms • Goals: resolu on acidosis,shock, trate dose • AE: GI- Yersina enterocoli ca, Pulm ? 24 hrs PE
73
Erythropoie n
• S mulate stem cells to mature RBCs • Side effects:↑Hct ↑plt ac vity, ↑systolic HTN -Hyperviscosity,HTN, Thromboembolism Chronic OD: Plethora, Black toes
74
25 Chemotherapeu cs
Chemotherapeu cs
Michael Policastro, MD Director, Medical Toxicology, QESI Clinical Assistant Professor, WSU
1
2
Cancer treatment strategy
• Cell surface receptor • Intracellular signal pathway • Cell maintenance process
3
1 Chemotherapeu cs
Classifica on Chemotherapeu cs
• Alkyla ng Agents: • An metabolite:- Methotrexate, Busulfan,Dacarbazine, Melphalan, fludarabine, mercaptopurine, Mustards (Chloramphenical pentostain,thioguanine, cyctaarabine, Cyclophosphamide, ifosfamide, Fluorouracil ( 5-FU) Mechlorethamine) Nitrosureas ( carmus ne) Pla noids (cispla n,carbopla n), • An mito c:Vinblas ne, Procarbazine ( hydrazine) Vincrisi ne,Paclitaxel, etoposide, teniposide • An bio c: • Biologics Anthracyclin (Danorubicin, Doxorubicin, Idarubicin,) • Radionuclides Mitoxantrone, Bleomycin, Mithramycin,Mitomycin, Mitoxantrone
4
Targeted Sites Of Ac on
Interphase: All phases except mitosis
DNA duplica on
5
Adverse effects
• Alkyla ng Agents: • An metabolites: mucosi s, Transamani s, pulm fibrosis, renal failure, n,v, transamini s, pancrea s, sz hyperuricemia,myelosuppression, *Cylophosphamide- hemorrhagic cys s due renal failure to ACROLEIN *carmus ne-toxic encephalopathy, * 5 FU –Cardiomyopathy, CHF *Cispla n- ototoxicity,re nal tox, renal failure, *carmus ne-hypersensa vity, skin ↓ lytes reac ons, BM suppression
• An bio c:Mucosi s, myelosuppression, dysrhythmias, • An mito cs: Autonomic cardimyopathy dysfunc on, dysrhythmias, *Bleomycin- Pulm fibrosis, BOOP myelosupression, SZ, Peripheral * Mitomycin C- Hemoly c uremic syndrome neuropathy, SIADH * Taxol- GI perfora on
6
2 Chemotherapeu cs
Methotrexate (MTX)
MTX Inhibits *Dihydro folate reductase (DHFR) * Thymidylate synthetase (TYMS)
N5-formyl FH4 (Leucovorin)
7
Methotrexate
• Inhibits DHFR, TYMS • Tri-phasic clearance, ( 2nd phase- renal clearance, 3rd phase ssue redistribu on into plasma) • Acidosis, renal failure, doses 100-1000mg/m2 associated with toxicity, folate deficiency • Toxicity primarily dependent on DURATION of exposure • Toxicity: Mucosi s,hepa s,renal failure, pancytopenia, seizures, hemiparesis,alopecia,olgiospermia,hypersensa vity pneumoni s
8
Treatment of MTX Toxicity
• Leucovorin 15mg/m2 • q 6 hrs x 2- 3 days un l MTX <5 x 10-8 • IVFS • Urinary Alkaliniza on • Hemodialysis • Thymidylate IV, carboxypep dase • Intrathecal MTX: CSF drainage/exchange
9
3 Chemotherapeu cs
Neurologic Adverse Effects
• AMS/SZ: MTX, Vincris ne, Mustards (Chloramphenical Cyclophosphamide, ifosfamide, mechlorethamine,carmus ne) • SZ: Chlorambucil/Ifosfamide- toxin (chloroacetaldehyde) • Cerebellar ataxia: 5-FU • Peripheral Neuropathies: vinca alkaloids , cispla n -( vincris ne>vinblas ne; sensory + motor and ascending) - taxol- primarily sensory • Cranial N ( 3-7, 10): vinca alkaloids • Tinnitus, hearing loss, re nopathy: cispla n
10
An -Microtubules
• Colchicine: Colchicum autumnale, • Paclitaxel: Taxus brevifola Gloriosa superba • Podophyllotoxin : Podophyllum - Meta-phase ( M) arrest peltatum - 3 phases tox: GI, Muli-organ failure, - derivates: etoposide, teniposide alopecia, Diabetes insipidus - Podophyllin more tox than - TX: MDAC, G- CSF derivates, similar tox colchicine - Podophyllin- M- phase • Vinca Alkaloids: Catharanus roseus
- Vincris ne most reported chemo OD in - Etoposide- inter-phase, lit. , - Severity: Vincris ne>vinblas ne topoisomerase II inhibitor - Vincris ne: Cri cal Neuro , SIADH - No specific an dote ( sensory/motor, ascending) - Vinblas ne: bone marrow - TX: Glutamic acid- neuro, Hyaluronidase- extravasa on injuries
11
Renal/Electrolyte Adverse Effects
• SIADH: Vincris ne • Diabetes Insipidus(DI) : Colchicine • Hemorrhagic cys s: Cyclophosphamide,Ifosfamide **toxin= acrolein • Renal Failure, Distal tubular necrosis: Cispla n • Hypomagnesium,Hypocalcemia: Cispla n
12
4 Chemotherapeu cs
Cardiac Adverse Effects
• Athracycline abx (Danorubicin, Doxorubicin, Idarubicin) —irreversible conges ve cardiomyopathy —immediate : dysrhythmia, pericardi s,myocardi s • Cyclophosphamide —CHF, hemorrhagic pericardi s, myocardial necrosis • 5-FU —vasospasm, myocardial ischemia, cardiogenic shock • Vinca Alkaloids Platelet aggrega on, coronary spasm ̶
13
Pulmonary Adverse Effects
• Bleomycin: pulm fibrosis, BOOP, nodular lesions • Methotrexate ( MTX): hypersensa vity pneumoni s, Hilar adenopathy • Cytosine arabinoside: non-cardiogenic pulmonary edema • Busulfan: alveolar-inters al proteinosis • Nitrosureas :Upper lobe pulmonary fibrosis
14
Mucosi s
• MTX • 5FU • Bleomycin • Doxorubicin
15
5 Chemotherapeu cs
An dotes
• Dexaroxane : Anthracycline ABX ( Doxurubicin) cardiomyopathy : Iron chelator • NA Thiosulfate: Cispla n • MESNA ( 2-mercaptoethane sulfonate sodium): cyclophosphamaide- inac vates acrolein to thioether • Methylene Blue: Ifosfamide encephalopathy • Amifos ne: Cispla n; ac vated intracellular by alkaline phosphatase, scavages free radicals • Folinic Acid: MTX • Glutamic Acid: Vincrisi ne – preven on neuropathy • DDTC (diethyldithiocarbamate) /Disulfuram: Cispla n, also recall Ni, Ni Carbonyl • KI: 131 Iodine • Prussian Blue: Thallium • DTPA: Plutonium • G-CSF: colchicine, most chemo agents • Pyridoxine: Procarbazine ( hydrazine)
16
Occupa onal Disulfuram Agents
Goldfrank’s Toxicologic Emergencies. 6th edi on. 2006. Figure 77.1 p.1177
Clinical Environmental Health and Toxic 17 Exposures .Sullivan and Kreiger.2001 . Table 18-4. P.238
Decontamina on/Elimina on
AC: MTX, busulfan, melphalan, chlorambucil MDAC: colchicine Urinary Alkaliniza on: MTX Plasmapharesis: Cispla n,Vincrisi ne
18
6 Chemotherapeu cs
Biologics ( MAB)
An -Inflammatories An -cancer • TNF inhibitors • GF/ Tyrosine Kinases • T cell inhibitors ( VEGF, PDGF, EGF) • IL inhibitors • Serine/threonine kinase • Leukocyte Integrin Blockers ( ATK) • Intracellular protein kinases ( RAS, RAF, APC) • Transcrip on factors/genes • G proteins • Phospholipases
19
Extravasa on An dotes
• Dimethyl sulfoxide (DMSO): topical: Antracyclines,Mitomycin: limits free radicals; compress- ICE • Dexrazoxane: IV: Anthracyclines: limits free radicals • Sodium thiosulfate: IV: Mechlorethamine: prevents ssue alkyla on • Hyaluronidase: SubQ : Vinca alkaloids,epipodophyllotoxins: degrades hyaluronic acid; compress- WARM
20
Regulatory Laws EPA Resource Conserva on and Recovery Act 40 CFR
Regulates 9 an -neoplas cs: arsenic trioxide, chlorambucil, cyclophosphamide, daunomycin, melphalan, mitomycin c, napthylamine mustasrd, streptozocin, uracil mustard
** Review Regulatory Laws and Programs
21
7 Chemotherapeu cs
22
23
24
8 Chemotherapeu cs
25
Transplant Immunosuppressive Agents
26
Transplant Biologics
27
9 Chemotherapeu cs
Calcineurin Inhibitors: cyclosproin/tacrolimus Side effects • Hypertension, Hyperlipidemia • Nephrotoxicity ( inhibi on pep dyl, prolyl-cis transisomerase) • Cardiovascular death increase • CSA: hirsui sm, gingival hyperplasia • Tacrolimus:DM
28
Calcineurin inhibitors : cyp3A4 drug interac ons
Increased levels Decreased levels • CCB • Rifampin • Emycin • CBZ, Phenobarb, Phenytoin • Fluconazole • Octreo de • Allopurinol • St. John’s Wort • Bromocrip ne • Colchicine • Metoclopramide • Protease inhibitors • Grape fruit juice
29
Sirolimus (Rapamycin)
• Macrolide compound, 3A4 • Inhibits IL-2/5, binds to kinase MTOR also known as FRAP, RAFT • MTOR: signal transduc on of GF, PI3 kinase, AKT/ protein kinase B pathway • Side effects:Hyperlipidemia, cytopenia, arthalgias, apthous ulcers, inters al pneumonia, hepa c artery thrombosis, wound dehiscence ( liver transplant)
30
10 Chemotherapeu cs
Mycophenolate Mofe l ( MMF) (Cellcept) • Blocks purine nucleo de synthesis inhibits type 2 IMPDH ( inosine monophosphate dehydrogenase) = inhibits conversion of IMP to GMP • No effect on cytokines • Side effects: GI, heme • Do not give with Azathioprine or other an - metabolites
31
MMF drug interac ons
Increased levels Decreased levels • Acyclovir,ganciclovir • Antacids: Al/Mg • Probenicid • Iron • Salicyaltes • Metronidazole • Sirolimus • Norfloxacin • rifampin
32
TNF-alpha contraindica ons
• Latent TB or Hep B • Chronic Heart failure • Vaccina ons with live organisms • Other possible side effects: infx, autoimmune disorders, uvei s, mul ple sclerosis, psoriasis, lymphoma
33
11 Chemotherapeu cs
TNF-alpha
34
Pregnancy And Immune Modulators
35
Pregnancy and Biologicals
36
12 Chemotherapeu cs
SERMs ( Selec ve estrogen receptor modifying drugs) Side effects • Tamoxifen , toremifene ( Fareston), fulvestrant(Faslodex) • Hot flushes, decreased bone mineral density premenopause • Thrombosis ( DVT, PE, Stroke) • Increased endometrial thickness, vaginal bleeding, ovarian cyst
37
Aromatase Inhibitors
• Anstrazole (Arimadex), exemestane (Aromasin),letrozole (Femara) • Side effects: menopause symptoms, muscle cramps • NO increase in endometrial cancer • Less effects than SERMS
38
Signal Transduc on Inhibitors: Tyrosine Kinase Inhibitors, side effec ts • EGFR:gefi nib(Iressa),erlo nib(Tarceva),cetuximab(erbitu x),panitumumab(Vec bix),( RASH-papulopustular, inters al lung disease, diarrhea) • VEGF:Vandetanib(Zac ma),Sorafenib(nexavar), suni nib(sutent), pazopanib (Votrient) ( coagulopathy, thrombosis) • Her-2:tratuzamab(Hercep n),lapa nib(Tykerb), pertuzumab (Omnitarg), fever, chills ( Anthracycline + her-2 = ventricular dysrhythmias, CHF) • BCR-ABL:ima nib mesylate ( Gleevac) ( edema) • Fusion protein EML4-ALK: Crizo nib(Xalkori)
39
13 Chemotherapeu cs
Signal Transduc on Inhibitors: mTOR • Temsirolimus (Torisel) • Everolimus (Afinitor) • Hypersensi vity reac ons, hyperglycemia • Opportunis c infec on • Bowel Perfora on • Coagulopathy • Avoid Live vaccines • CYP 3A4 interac ons
40
Signal transduc on: serine/threonine kinase BRAF • Vemurafenib (Zalboraf) • Rash, LFTS
41
Gene Expression/Cell Func on Inhibi on • HDAC( Histone Deacytylase):Vorinostat (Zolinza), Romidespsin (Istodax) Thrombocytopenias, rash • Re noids: Bexarotene (Targre n),Alitre noin (Panre n), Tres noin(Vesanoid) Pregnancy X, cataracts, rash/photosensi vity, LFTS
42
14 Chemotherapeu cs
Angiogenesis Inhibitor Bevacizumab (Avas n) • Endothelial VEGF • HTN, Thromboembolism, Bleeding • Proteinuria, impaired wound healing
43
Apoptosis Inducer
• Proteosome:Bortezomib (Velcade) • An folate: Pralatrexate (like MTX):accumulates in cells express RFC-1 protein
44
Immune Cell Modulators
• CD3: orthoclone OKT3 • CD20: Rituximab ( Rituxan), ofatumumab (Arzerra), ibritumomab (Zevalin),tositumomab HSV , dyspnea, inters al pneumoni s • CD30:Brentuximab (Adcentris) • CD33:Gemtuzumab • CD52: Alemtuzamab ( Campath) (ITP, autoimmune thyroid) • CTLA-4: Ipilimumav (Yervoy) • IL-2: Denileukin (Ontak), daclizumab (Zenapax) (CD25 , alpha chain IL-2)
45
15 Chemotherapeu cs
Rituximab( Rituxan) Side effects
• Monoclonal/chimeric an - CD 20 • HSV , dyspnea, inters al pneumoni s
46
Natalizumab (Tysabri) Side effects
• MAB against integrin • progressive mul focal leukoencephalopathy (PML) caused by reac va on of the JC virus, • hepatotoxicity
47
16 Plants
Poisonous Plants
ACMT Board Review Course September 9, 2012 Thomas C. Arnold, M.D.
1
Special Acknowledgement
• Thanks to Michelle Ruha and other previous presenters for their efforts on this topic.
2
Plants • Natural Products: 5% of tox boards – Includes food and marine poisonings, herbals, plants, fungi, toxic envenomations • ~ 5% of exposures reported to PCC each year, most in children < 6 years – Often a few deaths per year, but most reported exposures minor
3
1 Plants
Plant Poisoning by Organ System
• GI toxins • CNS toxins • Cardiovascular toxins • Multiorgan-system toxins • Hepatotoxins • Nephrotoxins • Endocrine toxins • Dermal and mucous membrane irritants
4
Lots of calls / Little threat • Euphorbia pulcherrima – Poinsettia • Ilex spp – Holly • Phoradendron spp – Mistletoe • Lantana spp • Spathiphyllum spp – Peace lily 5
• Ingestion of this plant may produce severe vomiting and diarrhea. Purple stains on fingers and a foamy quality to the diarrhea may provide a clue to the species of plant.
Pokeweed AKA Phytolacca americana
Toxin: phytolaccatoxin 6
2 Plants
Phytolacca americana
• Edible if parboiled • Root is the most toxic part, mature berries least toxic • Contains pokeweed mitogen – May see plasmacytosis
• Supportive care
7 Wikivisual.com
Solanum spp
wiki • 1700 species; nightshade, potato • Poisoning usually from ingestion of immature fruit • Solanine glycoalkaloids – Usually produce GI irritant effects – Hallucinations and coma reported
8
Melia azedarach
Toxin: meliatoxins
Chinaberry9
3 Plants
Chinaberry
• Tree grows to 50 feet • Native to Asia, grows in US • Fruit are green berries that turn yellow and remain after leaves shed • Fruit and bark poisonous • Vomiting and diarrhea • Care supportive
10
CNS Toxins
• Anticholinergic plants • Nicotinic alkaloid - containing plants • Hallucinogenic • Sympathomimetic • Epileptogenic
11
Jimsonweed
• 2 adolescent males eat these seeds
• 2 hours later, they are found stumbling, incoherent and their pupils look “blown” • In ED they are combative and hallucinating, have >8mm pupils, and are tachycardic in the 130s.
12
4 Plants
Datura spp
13
Datura spp • Along roadsides, pastures, waste areas • Leaves are long and lobed, with large white funnel-shaped flowers, entire plant toxic • Seed pods = spiny capsules with 50-100 seeds • Toxin = atropine, scopolamine, hyoscyamine • Symptoms begin 30-60 minutes after ingestion and continue 24-48 hours 14
leaves offset at stem
15
5 Plants
What is this plant?
Angel’s Trumpet
Brugmansia spp
16
Other anticholinergic plants to know…
• Atropa belladonna: Deadly Nightshade • Mandragora officinarum: Mandrake • Hyocyamus niger: Henbane • Anticholinergic plants
– Contain tropane (belladonna) alkaloids • atropine, hyoscyamine, scopolamine – Inhibit postsynaptic muscarinic receptors • Produce anticholinergic syndrome • Physostigmine will reverse 17
18
6 Plants
Nicotiana spp
• After ingesting a tea made of the leaves of this plant a patient developed tachycardia, vomiting and diarrhea, salivation, agitation, and convulsions
19
Tobacco Plants • Small plants, shrubs, or trees • Broad green leaves, tubular flowers • Pyridine-piperidine alkaloids • Ingestion, dermal absorption, inhalation – nicotinic syndrome (blockade of nicotinic acetylcholine receptors) • Harvesting wet leaves: green tobacco sickness • 1 cigarette or 3 butts toxic in a child 20
Plant / Toxin • N tabacum (commercial tobacco) – Nicotine • N glauca (wild tree tobacco) – Anabasine • N trigonophylla (desert tobacco) – Nicotine and anabasine • Lobelia inflata (Indian tobacco) – Lobeline Urinary metabolite of nicotine: cotinine 21
7 Plants
Commercial tobacco
Nicotiana tabaccum
Photos: wikipedia.com Tree tobacco Nicotiana glauca22
Plant: Conium maculatum Toxin: coniine
• A woman ate stems and roots from this plant. An hour later she developed vomiting and in the ED seized.
purple spots 23
Poison hemlock • Family Umbelliferae • Along roads and ditches and in wooded areas • Mistaken for wild carrots • Stems and leaves may be purple-spotted • Root most toxic part of plant 24
8 Plants
Betel Nut - Areca catechu
• ‘Quid’ chewed in Far East, Asia, India, South Pacific – Areca nut, betel leaf, lime paste, leaf tobacco • Toxin: arecoline – Nicotinic, muscarinic • Users have red-stained oral mucosa and saliva, dark- stained teeth 25
26
Mescal Bean Bush, AKA Texas Mountain Laurel Shrub with purple flowers, woody pods with bright red seeds
Contains: Cytisine
Latin: Sophora secundiflora 27
9 Plants
Others with nicotinic alkaloids
• Laburnum anagyroides – Golden chain tree • cytisine
wiikipedia • Caulophyllum thalictroides – Blue cohosh (herb) • N-methylcytisine in seeds, roots
28
Hallucinogenic Plants Toxin: ergine
Lysergic acid amide 10% potency of LSD
Ipomoea violacea - Morning Glory29
Argyreia nervosa
Hawaiian Baby Woodrose
Clinically, similar to LSD • euphoria, distortions of perception, hallucinations, panic, nausea and vomiting
30
10 Plants
Myristica fragrans Nutmeg
Seeds = nutmeg • This common household coating = mace spice must be taken in large doses to produce hallucinations • Toxin: myristicin, elemicin – metabolized to amphetamine-like compounds – produce a variety of CNS effects (stimulation to depression) 31
Claviceps purpurea
• Fungus that infects rye, other grains • The toxins are indole derivatives – Ergot alkaloids • ergonovine and ergotamine • Ingestion may produce ergotism (gangrenous or CNS, with hallucinations) 32
Peyote - Lophophora williamsii
• This cactus will make you vomit before you hallucinate
• structurally similar to The toxin: hallucinogen amphetamines mescaline • pharmacologically similar to hallucinogenic indoles
• emetic, hallucinogen, stimulant 33
11 Plants
Sympathomimetic
• The leaves of this plant are chewed in East Africa for stimulant effects • Plant: Khat; Catha edulis • Toxin: cathinone Qat man….wikipedia
– Structurally similar to amphetamines – Indirect sympathomimetic 34
Convulsant Plants
• Believing this to be a wild carrot, a man ingests a few bites from the root and within 30 min develops vomiting followed by seizures
35
OH
HOCH2(CH2)2-(C=C)2-(CH=CH)3-CHCH2CH2CH3 Toxin: cicutoxin A complex aliphatic alcohol
Cicuta maculata
Water Hemlock 36
12 Plants
Water Hemlock
• Umbelliferae family • Grows to 6 feet, compound leaves, small white flowers, chambered tuberous roots • Roots have a parsnip or carrot-like odor, and highest concentration of toxin • Rapid onset GI effects and seizures 37
This plant toxin antagonizes the glycine receptor, resulting in hyperreflexia and muscle spasms Treatment is benzos, barbs, paralysis, intubation Strychnos nux vomica Strychnine 38
Cardiovascular • Plant cardiac glycosides – Inhibit Na-K-ATPase – Clinically identical to digoxin toxicity – Cross react with digoxin assay but levels do not correlate with toxicity – Require higher doses dig Fab • Sodium channel openers • Sodium channel blockers
39
13 Plants
Cardiac Glycosides
• Foxglove – Digitalis lanata, D purpurea – Digitoxin • Purple, pink, white, yellow • Grows to about 3 feet • Whole plant toxic
40
Cardiac Glycosides
• Common oleander – Nerium oleander – Oleandrin wikipedia
• Lily of the valley – Convallaria majalis – convallotoxin, convallarin 41
Cardiac Glycosides • Yellow oleander – Thevetia peruviana – Thevetin
– AKA Lucky Nut
• Common method of suicide in Sri Lanka42
14 Plants
Cardiac Glycosides
• Red squill – Urginea maritima – Scillaren – Rodenticide
• Christmas rose – Helleborus niger – AKA Hellebore wikipedia 43
Sodium Channel Openers
• Grayanotoxins – Rhododendron – Azaleas – Mountain Laurels • Veratrum Alkaloids – Zigadenus spp – Veratrum spp • Aconitine alkaloids – Monkshood, Wolfsbane
– Aconite 44
Rhododendron spp
• Rhododendrons and Azaleas • Leaves toxic • Poisoning has resulted from ingestion of grayanotoxin-contaminated honey – reported in Turkey – ‘mad honey’
– AKA andromedotoxin 45
15 Plants
Veratrum Alkaloids
• False hellebore – Veratridine, germidine • Death camus – Zygacine, zygadenine • Mistaken for wild onions • Toxicity has occurred from sneezing powders made from pulverized roots
of Veratrum spp 46
Aconite
• Found in some herbals • All plant parts contain aconitine • All of the Na channel activators produce: – salivation, emesis, hypotension, bradycardia, arrhythmias, paresthesias, weakness – Effects 30 min to 6 hours following ingestion and persist several days
• Aconite also known for: torsades 47
Taxus spp The Yew Flat, needle-like leaves with black seeds surrounded by a (nontoxic) red aril Effects: N/V/D, arrhythmias, wide QRS What is the primary toxin? Taxine B
How does this toxin act? Na, Ca channel blockade 48
16 Plants
Multi-organ system toxins
• Cyanogenic glycosides • Toxalbumins • Mitotic Inhibitors
49
• A woman ingested a bag of apricot kernals she purchased at a health food store. About 50 min later she was comatose and acidotic.
• To what toxin was she exposed? – Amygdalin – A cyanogenic glycoside
50
Cyanogenic Glycosides
• Prunus spp – cherries, peaches, plums, apricots – Laetrile • Malus spp – apples • Cassava
51
17 Plants
Cyanogenic Glycosides
• Amygdalin - found in kernals and seeds • Hydrolyzed to hydrocyanic acid by beta- glucosidase (amygdalase) • Cyanide toxicity results – Clinically similar to other CN poisoning except delayed onset due to metabolism of amygdalin • Treated with cyanide antidote
52
Cassava
• Roots contain high concentration of the cyanogenic glycoside linamarin • Normally soak the roots to remove toxin • During droughts roots not soaked
Manihot esculenta
53
Chronic ingestion of Cassava may lead to…
Konzo Tropical Spastic Paraparesis Tropical Ataxic Neuropathy
• An upper motor neuron disease • Paresthesias, sensory ataxia, optic atrophy, sensorineural hearing loss 54
18 Plants
Chickling pea • Lathyrus sativa – AKA grass pea, sweet pea • Contains: BOAA
– Beta-N-oxalylamino-L-alanine wiki • Mechanism: AMPA glutamate receptor agonist, leads to degeneration of receptors • Poisoning occurs when this is main diet • Clinical: neurolathyrism, indistinguishable
from cassava-induced spastic paraparesis55
Toxalbumins • These plants contain toxins that bind the 60s ribosomal subunit, inhibit RNA polymerase: Inhibit protein synthesis • Mild symptoms: diarrhea • Severe: vomiting, diarrhea, abdominal pain, hypovolemia, hypokalemia, hepatorenal dysfunction, hyperthermia, seizures
56
Castor Bean - Ricinus communis
57
19 Plants
Castor Bean
• Large leafy plant with brown capsules containing three shiny, hard-coated seeds • Source of castor oil; toxin: ricin • Whole swallowed seeds not toxic • Toxic if chewed • Pure ricin injected IV much more toxic than ingested ricin
58
Jequirity Bean - Abrus precatorius
Toxin: Abrin
AKA rosary pea 59
Other toxalbumin- containing plants • Jatropha spp – Physic Nut – Contains: curcin • Phordendron spp – American mistletoe – Contains: phoratoxin • Robinia spp – Black locust
– Contains: robin wikipedia 60
20 Plants
Anti-mitotic toxins inhibit microtubule assembly (metaphase arrest) • Colchicine – Colchicum spp • Autumn crocus, meadow saffron – Gloriosa superba • Glory lily wikipedia • Clinically: severe GI sx and leukocytosis; then bone marrow suppression,
alopecia, peripheral neuropathy 61
Anti-mitotics • Podophyllum spp – Mayapple • Traditional Chinese herbal remedy wikipedia • Podophyllotoxin • Clinical: similar to colchicine, with GI effects followed by bone marrow suppression and peripheral neuropathy – Early CNS depression, no alopecia 62
Endocrine Grows in West Africa, West Indies, Central America, Florida Akee fruit Blighia sapida Which is toxic? Unripe fruit contains: Hypoglycin A 63
21 Plants
‘Jamaican vomiting sickness’ • Cases have occurred from canned fruit • Hypoglycin A – Inhibits beta-oxidation of fatty acids and gluconeogenesis – Metabolized to methylene-cyclopropyl acetic acid (MCPA), inhibits carnitine- acyl CoA transferase • Microvesicular steatosis, hypoglycemia, vomiting, seizures, death 64
Glycyrrhiza spp Licorice Root • Excessive ingestion may produce a hypermineralocorticoid syndrome – HTN, hypokalemia, edema, metabolic acidosis, weakness, muscle cramps
Glycyrrhizic acid inhibits 11β-hydroxysteroid dehydrogenase; can’t convert cortisol to cortisone 65
Hepatotoxins
• Pyrrolizidine alkaloids – Crotalaria spp – Heliotropium spp – Symphytum spp (Comfrey) – Senecio spp • Can cause hepatitis and hepatic venoocclusive disease
66
22 Plants
Rhubarb • Edible leaf stalk but raw leaf blades are toxic • Contain 1% soluble oxalates – Also anthraquinone glycosides that may cause GI distress • Rare renal dysfunction may occur
67
Dermal and Mucous Membrane Irritants
• Mechanical Stinging nettles • Chemical Urtica dioica • Allergic • Phototoxic
wiki 68
Mechanical and Chemical Dieffenbachia spp
• Common call to PCC when children chew on leaves and develop local pain
• Toxin: – Calcium oxalate
69
23 Plants
• Calcium oxalate crystals are packaged in raphides, arranged in bundles called idioblasts • When bite on leaf, idioblasts fire, depositing proteolytic enzymes with the raphides
• Results in pain and swelling • Potential for life-threatening airway obstruction 70
Other calcium oxalate containing plants • Philodendron spp • Caladium spp • Spathiphyllum spp
wikipedia 71
Agave
72
24 Plants
Capsicum annum Chili pepper • Capsaicin, in spices and pepper spray • Irritating to mucous membranes • May act through depletion of substance P from nerve terminals • Large oral exposure may cause gastroenteritis
73
Toxicodendron spp
poison ivy, poison oak, poison sumac Clusters of three leaflets, green and waxy appearing Oily resin - toxicodendrol, contains urushiol Contact dermatitis in susceptible people Resin under fingernails can continue to produce dermatitis if not removed 74
Allergic Plant Dermatitis
• Type IV hypersensitivity • Treatments: soap and water; steroids, antihistamines • Other plants – Ginkgo, mango, pistachio, cashew
75
25 Plants
Photodermatitis
• Psoralen in celery – Grocery workers • Photodermatitis – Allergen via dermal exposure or ingestion • Activated by light to produce rash
76
Major Summary Points
• Too many – • Suggested reading – Handbook of Poisonous and Injurious Plants by Nelson, Shih and Balick, Second Edition Springer, 2007 77
26 Historical Outbreaks
1
Toxic Outbreaks of Historical Importance
Stephen W. Munday, MD, MPH, MS Sharp Rees-Stealy Medical Group, Inc. San Diego Division, CA Poison Control System
Toxic Outbreaks of Historical 2 Importance
. Ergot Alkaloids – 12th Century France . Thousands affected (St. Anthony’s Fire due to Claviceps purpurea contamination of grain) Claviceps purpurea . Convulsive and/or Gangrenous forms
3 Lead, England 1700s . Devonshire Colic . Likely caused by lead-contaminated cider
1 Historical Outbreaks
4 Cadmium – Japan ~1910-1950s . Itai-itai – “Ouch-ouch” disease . So called due to severe pain from osteomalacia-induced fractures . Prevalence markedly increased in post-menopausal women. . Believed to be caused by cadmium-containing mine tailings that contaminated the irrigation water used to grow rice that was eaten by those affected.
5 Cobalt – Canada 1960s . Beer-drinker’s Cardiomyopathy . Co added to beer to stabilize the foam . Associated with cardiomyopathy in alcoholics but not non- alcoholics . Some have theorized this is due to thiamine deficiency since cobalt affects the thiamine pathway and alcoholics are often thiamine deficient. x =
Medicinal disasters: Thallium 6
. Location: US . Date: 1920s-1930s . Significance: Treatment of ringworm; 31 deaths
2 Historical Outbreaks
7 Medicinal disasters: Diethylene glycol . Location: US . Date: 1937 . Significance: Elixir of sulfanilamide contaminated by DEG caused over 100 deaths due to renal failure . Led to passage of Food, Drug & Cosmetic Act in 1938.
Medicinal disasters: Thorotrast 8
. Location: US . Date: 1930s-1950s . Radiographic contrast agent containing thorium dioxide that was concentrated in the RES including the liver and spleen . Significance: Hepatic angiosarcoma rate increased over 100 fold
9 Medicinal disasters: Phenobarbital
. Location: US . Date: 1940-1941 . Significance: Sulfathiazole antibiotic contaminated with phenobarbital; 82 deaths
Phenobarbital Sulfathiazole
3 Historical Outbreaks
Medicinal disasters: Diethylstilbestol (DES)10
. Location: US, Europe . Date: 1940s-1970s . Used to prevent miscarriages or premature delivery . Significance: Endometrial/Cervical/Vaginal carcinoma in daughters, Testicular cancer in sons & Breast cancer in users.
Medicinal disasters: Stalinon 11
. Location: France . Date: 1954 . Significance: Severe neurotoxicity including cerebral edema from triethyltin – used to treat boils
Medicinal disasters: Clioquinol 12
. Location: Japan . Date: 1955-1970 . Used topically and orally as an antibacterial and antiparasitic agent . Significance: Subacute myelooptic neuropathy (SMON); 10,000 symptomatic with a syndrome that involves sensory and motor disturbances in the lower limbs and visual changes; some had green tongues . Never noted before or after this period so many are not convinced clioquinol was the cause
Bonus: What’s this?
4 Historical Outbreaks
13 Medicinal disasters: Thalidomide
. Location: Europe . Date: 1960s . Used as a sedative and anti-nausea drug in pregnant women . Significance: 5000 cases of phocomelia (fore-limb shortening) in Europe; it never was approved in the US
Medicinal disasters: Pentachlorophenol14
. Location: US . Date: 1967 . Used in hospital laundry . Significance: 9 neonates ill, 2 deaths. . Presented with: fever, sweating, renal failure and acidosis
15 Medicinal disasters: Benzyl alcohol
. Location: US . Date: 1981 (MMWR June 11, 1982) . Used as a preservative in IV solutions . Significance: Gasping syndrome / acidosis seen in neonates receiving large amounts of benzyl alcohol via IV solutions . Disappeared once benzyl alcohol exposure to neonates was limited
5 Historical Outbreaks
Medicinal disasters: Acetaminophen-cyanide16
. Location: Chicago . Date: 1982 . Significance: Tampering incident resulted in 7 homicides due to cyanide poisoning
17 Medicinal disasters: L-Tryptophan
. Location: US . Date: 1989 . OTC supplement . Significance: Eosinophilia-myalgia syndrome . Scleroderma-like skin changes associated with eosinophilia and myopathy . Epidemiologic and chemical evaluation suggested that it MAY have been due to contaminated L-tryptophan from a single manufacturer . Similar to 1981 Spanish toxic oil syndrome
18 Medicinal disasters: Diethylene glycol
. Location: Haiti . Date: 1996 . Significance: Acetaminophen elixir contaminated with DEG; renal failure; >88 pediatric deaths
6 Historical Outbreaks
Toxic Outbreaks of Historical 19 Importance
. Methylenedianiline – Epping, England, 1965 . Contaminated flour caused 84 cases of cholestatic jaundice
Toxic Outbreaks of Historical 20 Importance
. Hexachlorobenzene – Turkey, 1956 . Wheat seed with fungicide was eaten instead of planted . ~4,000 cases of porphyra cutanea tarda
Toxic Outbreaks of Historical 21 Importance cont’d
. PCBs (polychlorinated biphenyls) &PCDFs (polychlorinated dibenzofurans) . Japan, 1968: Yusho or Rice oil contaminated by heat-exchange fluid from a leaking pipe 1,600 affected . chloracne, hyperpigmentation and increased liver cancer and reproductive effects . Taiwan, 1979: Yu-Cheng (Oil Disease) 2,000 affected . Similar to Yusho Effects
7 Historical Outbreaks
Toxic Oil Syndrome 22
. Spain, 1981 . Associated with 2% aniline denatured rapeseed oil . Scleroderma-like plus eosinophilia and pulmonary hypertension . Caused over 600 deaths . 1989 Eosinophilia-myalgia syndrome possibly associated with some tryptophan supplements was clinically similar
23 Arsenic
. France, 1828 . 40,000 with neuropathy due to arsenic in bread and wine . Staffordshire, England 1900 . Arsenic-contaminated sugar in beer with 6,000 cases of neuropathy and 70 deaths
24 Arsenic
. Bangladesh/West Bengal India . Arsenic contaminated ground water from wells . 60 million exposed in Bangladesh alone . Over 220,000 in West Bengal affected (skin changes/skin cancer)
8 Historical Outbreaks
Methyl Mercury 25 . Minamata Bay, Japan 1930s-1950s . Industrial waste contaminated with inorganic Hg was concentrated up the food chain as methyl Hg after being dumped in the bay. . Many cases of methyl Hg poisoning in humans & animals who ate seafood from the bay . Iraq, 1971 . Methyl Hg treated seed grain intended for planting was mistakenly ingested . >400 deaths
Minamata Disease
26 Methyl Isocyanates
. Bhopal, India 1984 . A series of safety factors that were not appropriately engaged, led to an explosion that released methyl isocyanate . Many humans & animals were acutely affected – . skin, mucous membranes and respiratory tract. . Estimates vary but thousands died acutely and likely hundreds of thousands were injured (many with residual effects)
Bhopal, India 27
9 Historical Outbreaks
Triorthocresyl Phosphate (TOCP) 28 . US 1930-1931 (“Prohibition”) . Alcohol containing patented “medication” (“Jake”) from Jamaican ginger was formulated with TOCP and caused upper and lower extremity neuropathy . Similar to OP pesticides . 50,000 people developed Ginger Jake Paralysis
2, 3, 7, 8 TCDD (Dioxin) 29
. Seveso, Italy 1976 . A nearby 2, 4, 5, trichloropheroxyacetic acid (2, 4, 5 T) facility exploded . Chloracne developed in those most exposed . No clear evidence of increased cancer risk in this group . This industrial accident led to the Seveso Directive (European Community Industrial Safety Regulations)
30 Chloracne due to Dioxin Poisoning
Ukrainian President Viktor Yushchenko
10 Envenomations
Envenomations
ACMT Board Review Course September 9, 2012
Thomas C. Arnold, M.D.
1
Special Acknowledgement
• Thanks to Michelle Ruha and other previous presenters for their efforts on this topic.
2
What to Review? • Natural Products: 5% of tox boards – Includes food and marine food poisonings, herbals, plants, fungi, toxic envenomations • Toxic Envenomations – Marine, snakes, lizards, scorpions, spiders, bees, ants, caterpillars, other random things (blister beetles, toads, newts, etc…) – Native AND non-native!!! 3
1 Envenomations
Keep in Mind
• This presentation attempts to include most important points for the boards – A lot of things not included
• All venoms are ‘complex’ – Will leave out lists of components and try to include the ones to remember (for the most part)
4
Marine Envenomations
• Stingrays • Cnidaria • Scorpaenidae – Jellyfish • Sea snakes • True, ‘not’ true – Fire coral – Anemones – Corals • Echinodermata • Mollusks • Sponges 5
Stingray / Dasyatis spp
• Most common stinging fish • Atlantic / Mediterranean / Indian Ocean • Spine on dorsum of tail has sharp tip and barb, with venom glands under spine – Lacerates and envenomates – A sheath surrounds the spine and may become embedded in wound 6
2 Envenomations
Stingrays
• Extremity injuries - deep ulcers and secondary bacterial infections • Chest injuries - death • Venom produces edema and pain out of proportion to visible tissue injury – Peaks at 60 min, may last 48 hours – Systemic: cramping, weakness, N/V/D • Wound initially cyanotic or dusky, becomes 7 erythematous, necrotic
Management
• Cleanse, explore, debride wound • Tetanus prophylaxis • Prophylactic antibiotics (Cipro, Bactrim, Tetracycline okay) • Pain control: hot water, analgesics • Don’t suture
8
Scorpaenidae
• Next most common fish envenomations • Over 350 species; found in coral reefs • Spines with venom glands • More venomous: Gulf of Mexico, Pacific & Indian oceans • Less venomous: Ca and SE US coasts • Victims: scuba divers, snorkelers, fishermen; people with imported fish in
home aquariums 9
3 Envenomations
Least Scorpaenidae severe • Pterois – Lionfish – Rather escape • Scorpaena – Scorpionfish • Synanceja – Stonefish Most severe– Rather attack 10
Scorpaenidae • Venom – Inflammatory mediators (lionfish) – Stonustoxin, verrucotoxin, catecholamines (stonefish) • Clinical: spectrum, ranges from local with Lionfish to severe with Stonefish – Local - Erythema, pain, induration – Systemic - N/V, syncope, arrhythmia, seizure, pulmonary edema, death 11
Management • Hot water (110-115ºF) inactivates toxin • Analgesic or digital nerve block • Remove barbs or spines • Tetanus • Consider prophylactic antibiotics • Antivenom for life-threatening stonefish envenomation - equine Fab • Don’t suture
12
4 Envenomations
Sea Snakes • Hydrophiidae Hydrophis • >50 species – all venomous cyanocinctus • None in Atlantic or Caribbean • Some relevant species: – Enhydrina schistosa (beaked) – Pelamis platurus (pelagic) – Astrotia stokesii – Hydrophis ornatus 13 – H. cyanocinctus (banded)
Sea Snakes • Front fixed fangs, 80% dry bites • Similar to Australian Elapids • Venom extremely toxic – Neurotoxins, myotoxins • Symptoms within minutes to hours • Minimal local reaction • Ascending paralysis, rhabdomyolysis • No coagulopathy
14
Antivenom
• Treat symptomatic envenomations • Equine-derived, available in Australia • Prepared against Enhydrina schistosa (beaked sea snake) and Notechis scutatis (terrestrial tiger snake)
15
5 Envenomations
Cnidaria • Formerly Coelenterata • > 9000 species, grouped: – Hydrozoans (man-of-war) – Scyphozoans (true jellyfish) – Cubozoa (box jellyfish) – Anthozoans (corals, anemones) • Most contain nematocysts
16
Nematocysts
• Dart-like structures enclosed within venom sacs • Stimulated by pressure / chemical signals • Shoot out of containment sacs, injecting venom as they penetrate flesh
17
Cnidaria • Venom: inflammatory mediators, proteases • Spectrum of severity – Mild: dermatitis, pain – Severe: multi-organ toxicity, death – Anaphylactoid reactions may occur • May be inactivated by 5% acetic acid solution (vinegar) • Antihistamines or steroids prn 18
6 Envenomations
Jellyfish • Long tentacles contain hundreds of thousands of nematocysts • Stinging sensation, pruritus, paresthesias, central radiation of pain • Red-brown-purple lesion in a linear whiplike pattern • Blistering, edema, violaceous petechial hemorrhages 19
Box Jellyfish
• Chironex fleckeri • Off Australia and SE Asia • Most venomous of all stinging marine life • Venom produces catecholamine surge
20
Box Jellyfish • Most victims with severe pain only • Wounds may become necrotic • May develop acute and/or delayed hypersensitivity • Severe: Hypotension, cardiac arrhythmias, respiratory failure, anaphylaxis • Death more common in kids, occurs fast
• Sheep derived whole IgG AV in Australia21
7 Envenomations
Portuguese Man-Of-War • Physalia physalis • Waters along the Florida coast • Tentacles up to 10 feet, nearly transparent • Venom may cause excruciating pain • Rare cardiac arrhythmia, respiratory failure, anaphylaxis, death
22
Irukandji Jellyfish
• Carukia barnesi • Peanut-sized, translucent jellyfish – Australia’s north coast, Pacific, Florida (different species?) • Relative of the box jellyfish • Catecholamine surge, with cardiac and pulmonary effects, death may occur • No antivenom
23
Sea Bather’s Eruption
• AKA ‘sea lice’ • Larvae of jellyfish Linuche unguiculata • Between March and June, SE Florida • Pruritic, erythematous, maculopapular rash in areas covered by bathing suit • Symptoms resolve spontaneously hours to days, up to 2 weeks
24
8 Envenomations
Fire Coral • Millepora spp • Not a true coral • Most commonly found in shallow tropical waters • Sharp skeleton, contain nematocysts • Divers at risk: contact may result in burning pain, urticaria, pruritis • Wheals may take weeks to resolve and
may leave a hyperpigmented scar 25
Anemones
• Flowerlike appearance • Modified nematocysts known as spirocysts • Humans stung when handling them • Varies in severity, from stinging sensation to vesiculation, necrosis
26
Cnidaria Treatment • Supportive care / tetanus • Vinegar often first line – Inhibits d/c of nematocysts from C fleckeri – May increase d/c in some species • Irrigation with seawater may be better in US • Pain may resolve spontaneously in 30-90 min • Antihistamines / corticosteroids prn
• No prophylactic antibiotics 27
9 Envenomations
Echinodermata
• Starfish • Sea urchins • Sea cucumbers
28
Mollusks: Cone Snails
• 300 Conus species • Stings with a modified tooth fired from the proboscis • Venom contains conotoxins – neurotoxins which target multiple specific ion channels • Ziconotide, a conotoxin derivative, is being used to treat neuropathic pain
29
Cone Snails • Local pain, burning sensation, numbness, ischemia, paresthesias • Most cases only local manifestations with resolution in 6-8 hours, although deaths have been reported • Progression to generalized paresthesias, paralysis, respiratory failure, coma, cardiac failure
• Treatment – hot water, supportive 30
10 Envenomations
Mollusks: Blue Ringed Octopus • Found in Indo-Pacific shallow waters • Small, up to 20 cm • Usually harmless, bites rare • Two sets of salivary glands that release venom from a powerful parrotlike beak • Venom contains tetrodotoxin (aka maculotoxin )
– Blocks sodium channels 31
Blue-Ringed Octopus (Hapalochlaena spp) • Initially mild local pain, burning, numbness, ischemia; local progressing to perioral and distal paresthesias • May rapidly progress to paralysis, respiratory failure • Treatment supportive
32
Snakebites
• >8000 bites / year in US; <10 deaths • > 99% venomous bites in US Crotalinae • Snake Families: Crotalinae – Viperidae subfamilies Viperinae – Elapidae – Hydrophiidae – Atractaspididae
– Colubridae 33
11 Envenomations
Colubridae • Rear fixed fangs • Found in most parts of the world • Most species harmless – garter, gopher, sonoran vine snake • Some dangerous, even lethal – Clinical effects: swelling and coagulopathy
34 Rat snake
Atractaspididae • Rear/lateral – directed front fangs • Africa, Middle East • Pain, swelling, lymphadenopathy, vomiting, diaphoresis, fever, coagulopathies
35 African Burrowing Asp
Elapidae • Front, fixed fangs • 60% bites dry • Often neurotoxic venom Krait • Some non-native species: (Malaysia, India)
Cobra Mamba Tiger Snake 36
12 Envenomations
US: Eastern Coral Snake • Micrurus spp • Red on yellow complete bands • Neurotoxic venom: paralysis, symptom onset may be delayed many hours • Treat with antivenom early, if available
• Sonoran coral snake (Micruroides)
- not dangerous 37
Red on yellow, kill a fellow
Red on black, venom lack 38
Viperidae
• Viperinae - old world vipers • Crotalinae - new world or ‘pit’ vipers • Front, mobile fangs • 25% bites dry • Venom into dermis/SQ, to lymphatics • Local tissue effects, hematotoxicity, some neurotoxic
39
13 Envenomations
Viperinae • Old World Vipers • Found in many European and Asian countries, Middle East, Africa • No heat sensing pits
Puff Adder Asp Viper
40 Russell’s Viper African Gaboon Viper
Crotalinae • Pit vipers • Triangular shaped head • Heat sensing pits, elliptical pupil • North, Central, and So America, Asia • In US: all states except ME, AK, HI – Crotalus - Most rattlesnakes – Sistrurus - Massasauga, pigmy – Agkistrodon - Copperhead, cottonmouth 41
US Pit Vipers
Rattlesnakes (Crotalus and Sistrurus)
Copperhead (Agkistrodon) Cottonmouth42
14 Envenomations
US Pit Vipers • Venom Toxicity – Rattlesnakes > cottonmouths > copperheads
• Venom: cytotoxic, myotoxic, hemotoxic, occasionally neurotoxic
43
Rattlesnake Venom (a few of many components) • Fibrinolytic, fibrinogenolytic enzymes – Defibrination, coagulopathy • Thrombin-like enzymes – Coagulopathy • Metalloproteinases – Tissue damage • Phospholipases – Thrombocytopenia, neurotoxicity • Bradykinin-potentiating peptides 44 – Anaphylactoid reactions
Venom Neurotoxins
• Postsynaptic neurotoxins – α neurotoxins – Most elapid and sea snake venoms – Competitively bind nicotinic acetylcholine receptors and produce a nondepolarizing neuromuscular blockade • Neostigmine may reverse 45
15 Envenomations
Venom Neurotoxins
• Presynaptic neurotoxins – β neurotoxins – Some elapid and viper venoms – Inhibit release of acetylcholine at the neuromuscular junction
46
Rattlesnake Neurotoxicity
• β neurotoxins – Common in Mojave and Southern Pacific (C. scutulatus and C. helleri) – Crotoxin, in South American rattlesnake (C. durissus terrificus)
• Fasciculations most common • Severe cases progress to weakness and paralysis with respiratory failure 47
Physical Exam • Tenderness, swelling, ecchymosis • Variable # puncture wounds; oozing • Axillary or inguinal tenderness • Possibly: vomiting, diarrhea, bleeding, tachycardia, fasciculations, erythema near bite, hypotension, angioedema • Rare: DIC, compartment syndrome, anaphylaxis • Labs: low platelets, low fibrinogen, high
PT, high FSP; hemoconcentration 48
16 Envenomations
Local: oozing at bite site, ecchymosis
Severe swelling, third spacing
49
Tissue necrosis, hemorrhagic blisters at bite site – usually with bites to digit
50
Management • IV fluids • No pressure bandages, incision, suction, tourniquet, extractors, etc… • No prophylactic antibiotics • Pain meds • Occasional epinephrine drips prn • Consider antivenom • No blood products unless actively bleeding AND giving antivenom
– Not ‘nuisance bleeding’ 51
17 Envenomations
Antivenom Indications
• Progressive swelling • Thrombocytopenia • Coagulopathy • Neurotoxicity • Shock
• No contraindications
52
Antivenom:CroFab Crotalidae Polyvalent Immune Fab (ovine)
• Sheep derived using Mojave, Western and Eastern Diamondbacks, Cottonmouth • Stops progression of swelling • Usually reverses hematologic toxicity • May prevent compartment syndrome • No evidence that prevents tissue loss 53
Antivenom
• Goal: gain ‘control’ of envenomation – Stop progression of swelling and reverse hematologic abnormalities
– May need to give maintenance doses after establishing control to prevent recurrent venom effects in first 24 hours after control 54
18 Envenomations
Management
• Beware – Late onset coagulopathy or thrombocytopenia – Recurrence of hematologic findings
– May be many days after AV, requires close out-pt follow up 55
All Antivenoms May Produce Hypersensitivity Reactions • Acute anaphylactoid – Most common, rate-related • Acute anaphylaxis – IgE mediated, type 1, pre-sensitized • Above treated with antihistamines, epi prn • Delayed (type IV) serum sickness – 3 - 21 days, rash / fever / arthralgias – Treat with steroids / antihistamines 56
Special Populations
• Pregnant - case reports suggest poor fetal outcome if first trimester – Most would aggressively treat with AV although not studies
• Children - no AV dose adjustments
57
19 Envenomations
Exotic Snakebites
• Attempt to identify species and locate appropriate specific AV – Patient, local zoo, poison center, Antivenin Index, etc… – Do not reflexively administer CroFab • Supportive care
58
Venomous Lizards
• Gila Monster - Heloderma suspectum – Desert areas of southwestern US • Beaded Lizard - Heloderma horridum – Mexico • Large, nocturnal, slow, shy • Forceful bite - only if handled – Difficult to disengage, teeth may break off in the wound 59
Gila Monster
• Venom contains helothermine • Poor delivery system (grooved teeth) • Local pain, tenderness, and edema • Occasional anaphylactoid reactions • No antivenom • Treatment: antihistamines, steroids, epinephrine; airway protection
60
20 Envenomations
Angioedema after gila monster bite
61
Arthropod Envenomations
• Native Spiders – Black widow – Brown Widow – Brown recluse • Non-native – Funnel web • Scorpions
• Hymenoptera 62
Widow Spiders
• Many species worldwide • US: ‘Black widow” = Latrodectus mactans, L hesperus, L variolus, L geometricus • L mactans: shiny black with ventral red hourglass on belly • Venom neurotoxic: α-latrotoxin – Causes release of neurotransmitters from presynaptic nerve terminals
63
21 Envenomations
Black Widow Spider Bite • +/- fang marks with surrounding erythema • 15 min - 6 hrs, “latrodectism” • Characteristic feature: pain • Neuromuscular: cramps, rigidity, tremor, weakness, priapism, uterine contractions • Cardiopulmonary: HTN, tachycardia • Systemic: nausea, diaphoresis, salivation, urinary retention • Latrodectus facies: periorbital swelling, grimacing 64
Black Widow Treatment • Recovery usually in 24 to 48 hours • Supportive care – Analgesics – Benzodiazepines
– If this fails: • 1 vial equine whole IgG AV – Antivenin (Latrodectus mactans) (Equine) – Analatro Fab2 antivenom is in
clinical trail phase presently 65
Brown Recluse Spider
• Loxosceles reclusa – AKA Fiddleback Spider • Violin-shaped mark on cephalothorax • Other Loxosceles: unlikely to interact with humans as much but can probably produce wound • Very reclusive spider, bites uncommon and over-diagnosed
66
22 Envenomations
Brown Recluse Spider
• Venom – sphingomyelinase D: necrosis, hemolysis – Hyaluronidase: facilitates spread of venom
– Leads to neutrophil migration to bite site, inflammation, clotting of small vessels, ischemia, necrosis 67
Brown Recluse Spider • May have only mild and transient skin irritation • May develop dermonecrosis – Blisters, bleeds, ulcerates in 2-8 hours (red, white, and blue lesion) – Lesion may enlarge for a week – Healing may take months • Erythema is gravitational 68
Brown Recluse Spider • Systemic involvement uncommon – More frequent in children – Usually 1-3 days after bite • Fever, chills, nausea, rash, arthralgias, DIC, hemolytic anemia, and renal failure • Treatment: supportive care, delayed debridement for large necrotic wounds; steroids recommended for hemolysis • Evidence does not support dapsone, HBO use in humans 69
23 Envenomations
Non-native: Funnel Web Spider • Atrax robustus • Australia; Sydney funnel web spider • Venom neurotoxic – Robustoxin (atraxotoxin) – NT release • Clinical: no necrosis; autonomic storm, with AMS, HTN, pulmonary edema, muscle writhing, salivation….. • Pressure immobilization
• Rabbit-derived IgG antivenom 70
Scorpions
• 1500 species, 30 dangerous • All dangerous in Family Buthidae – In No America, all Centruroides • In US, single species dangerous – Centruroides sculpturatus • All have venom that affects neuronal sodium channels and causes excessive NT release
71
Clinical Effects • Neurotoxic venom produces – Pain, paresthesias – Neuromuscular agitation
• Most dangerous species – Autonomic storm, cardiovascular collapse, pulmonary edema, death
72
24 Envenomations
The Bark Scorpion • 15-20,000 calls/year to AZ PCCs • 95% mild, managed at home – Grade 1, local pain – Grade 2, distal paresthesias • Severe (Grade 3, 4) mostly peds – Roving eye movements (opsoclonus) – Neuromuscular agitation – Hypersalivation, tachy, fever 73
The Bark Scorpion
• Management – Supportive, with benzodiazepines, opioids, airway protection – Monitor for rhabdomyolysis, aspiration pneumonia – In August 2011 Anascorp® (produced from the Mexican Centruroides species) was approved by the FDA
74
Tick Paralysis
• US - Dermacentor andersoni • US - Dermacentor variabilis • Australia - Ixodes holocylus
• Cases in US in northwest • As tick feeds on blood, secretes venom into host which is absorbed systemically • Neurotoxin: inhibits release of ACh at NMJ 75
25 Envenomations
Tick Paralysis: Clinical
• Tick on person for 4-6 days • Initially: weakness, lethargy, ataxia, • Then: ascending paralysis beginning in lower extremities, can progress to bulbar within 48 hours, can lead to respiratory weakness, death • Absent or decreased DTRs • Treatment: remove tick, supportive
76
Hymenoptera
• Apidae: honeybees, bumblebees – Can sting only once • Vespidae: Wasps, hornets, yellow jackets • Formicidae: Fire Ants
Most common reactions are allergic
77
Africanized Honeybees
• Apis mellifera scutellata • Aggressive, can attack in thousands
• Venom: – Melittin - main component, disrupts cell membranes – Phospholipase A2 - major allergen
78
26 Envenomations
Africanized Honeybees
• > 50 stings may cause systemic toxicity – Vomiting, edema, rhabdomyolysis, hemolysis, DIC, death (>500 stings) • Treatment: supportive care with IVF and pain control, antihistamines and steroids prn, epinephrine prn • Remove stingers by any method 79
Fire Ants: Solenopsis spp
• Solenopsis invicta – Southern US, imported from S America • Grabs skin with mandibles and stings in a circle around bite • Burning pain, wheals evolve to wikipedia pustules, can necrose • Can have systemic and anaphylactic reactions
80
Caterpillars / Lepidopterism
• US most important is Megalopyge opercularis – AKA puss caterpillar or wooly slug – an urticarial toxin can produce severe pain, swelling and erythema • In South America, the most medically important in the world: Lonomia obliqua – pain, coagulopathy, renal failure, DIC
– Antilonomic serum (SALon) in Brazil 81
27 Envenomations
Toads • Bufo spp – Bufo marinus - Cane toad – Bufo alvarius - Colorado River toad • Bufotoxins – Indolealkylamines: hallucinogenic – Bufadienolides: inhibit Na-K-ATPase • Toad licking, toad soup, aphrodisiac preps – cardiac toxicity • Can treat arrhythmias with digibind
82
Major Summary Points
• Stinging fish – hot water inactivation • Nematocysts – acetic acid inactivation • Rattlesnakes – cyto and hemotoxicity • Black widow – pain and hypertension • Brown recluse – necrotic wounds • Bark scorpion – hypersalivation, opsoclonus, neuromuscular toxicity • Massive honeybee - toxic reaction to mellitin – rhabdo, DIC 83
28 Carcinogens
Carcinogenesis
Stephen W. Munday, MD, MPH, MS Sharp Rees-Stealy Medical Group, Inc. San Diego Division, CA Poison Control System
1
Objectives
• Provide a brief framework and terminology for understanding toxic carcinogenesis • Provide an organized database to prepare for the board exam
2
Epidemiology of Cancer
Doll & Peto, 19813
1 Carcinogens
Definitions
• Mutagen – A substance that alters DNA • Carcinogen – A substance that increases the frequency or severity of cancer over background rates • Proximate carcinogen – intermediate forms • Procarcinogen – Requires metabolic activation • Ultimate carcinogen – the form actually causing the injury
4
Carcinogen Activation
H2N NH2 Benzidine (Procarcinogen) N-Hydroxylation
O H O
C N N C
H3C OH CH3 N hydroxy dacetyl Benzidine (Proximate Carcinogen) ] O H + C N N H C H 3 ] N Acetyl Benzidine Nitrenium ion (Ultimate Carcinogen)5
Most widely accepted model of environmental carcinogenesis Linear No-Threshold Effect Multistage Model of Carcinogenesis • Developed from radiation exposure – not chemicals • Not validated for low doses or low-dose rates
• From the New England Journal of Medicine (2007)
6
2 Carcinogens
7
8
Model’s Presumed Dose/ Response Relationship
Experimental Data
Response
Extrapolated Data Hormesis Dose • Most closely describes initiating agents • Assumes that the curve is linear to zero and that dose rates are unimportant • Ignores experimental evidence for hormesis (Decreased rates at low doses presumably due to cellular repair mechanisms) 9
3 Carcinogens
Classification of Chemical Carcinogens in Relation to their Action on One or More Stages of Carcinogenesis • Initiating agent: an agent capable of initiating cells by producing a heritable DNA alteration (ex. Alkylating Agent, Radiation) • Promoting agent: an agent capable of causing the expansion of initiated cell clones (ex. Hormones) • Progressor agent: an agent capable of converting an initiated cell or a cell in the stage of promotion to a potentially malignant cell (increasing karyotipic instability)
Complete carcinogen: an agent possessing the capability of inducing cancer from normal cells, usually possessing properties of initiating, promoting and progressor agents 10
Initiation • Initiation often occurs as the result of irreversible DNA alteration that either activates oncogenes or inactivates tumor suppression genes • Oncogenes primarily affect cellular growth, signal transduction and nuclear transcription (ex. ras) • Tumor supressor genes regulate cell growth and division (ex. p53, BRCA1) • When the DNA alteration occurs in germ cells, it is then heritable. (2 Hit Theory) 11
Promotion
• A reversible process that works by altering gene expression often by interfering with signal transduction • The process requires ligand-receptor interactions and therefore often demonstrates a sigmoid shaped dose/ response relationship • Some promoters demonstrate hormesis – a protective effect at low doses
12
4 Carcinogens
Dose/Response Relationship No Range of Maximum response increasing response range response with range increasing dose Threshold Threshold Increasing Response Increasing
Increasing Dose 13
Examples of Mechanism of Promotion
14
Steroid Tyrosine Kinase G protein-linked
Plasma Membrane AC Cytoplasm Ras Tyrosine G Protein Sos GDP GTP Kinase Receptor B-raf PKA HSP90 MEK Phosphorylation
MAPK
Dimerization RSK Nuclear Membrane Nucleus Transcription p19arf E2F CREB REB HRE 15
5 Carcinogens
Progression
• Irreversible progressive karyotype instability associated with further DNA alteration over time
16
Examples of Organizations with Carcinogenesis Classifications • United Nations (WHO/ • ACGIH (American IARC & GHS*) Conference of Governmental Industrial Hygienists) [*Globally Harmonized System] • OSHA/(IARC, NTP, • EPA (USA) 29CFR1910Hazcom • NTP (USA) Publisher of subpart Z) Review of Carcinogens (RoC), 12th edition currently
17
Inter-Agency comparisons
IARC GHS NTP ACGIH EU Group 1 Cat. 1A Known A1 Cat. 1 Group 2A Cat. 1B Reasonably A2 Cat. 2 suspected Group 2B Cat. 2 A3 Cat. 3 Group 3 A4 Group 4 A5
18
6 Carcinogens
• FDA (National Center for Toxicology Research) • NIEHS/(NIH) • NIOSH/CDC
19
IARC International Agency for Research on Cancer (WHO/UN) [05/2012] Carcinogen Classification
Group 1 Known Human Carcinogens (107) Group 2A Probable Human Carcinogens (63) Group 2B Possible Human Carcinogen (271) Group 3 Not Classifiable (509) Group 4 Probably Not Carcinogenic (1)
20
IARC Classification Data Analysis
Based on: • human epidemiology • in vitro • animal experiments • Other relevant data (SAR, ADME, Dose/ Response, Repair Mechanisms) • They do not conduct the experiments, they just review the data. 21
7 Carcinogens
IARC Classification, cont’d
• Human Epidemiology – frequently involves occupationally exposed cohorts but also case/control or ecologic studies • Generally preferred for IARC 1 classification but exceptions exist (ethylene oxide, neutrons)
22
IARC Classification: in vitro tests Test Endpoint Gene mutation assays in vitro Prokaryote mutagenesis in Back or forward mutations vitro (Ames’ test, etc.) in specific bacterial strains Mouse lymphoma thymidine Mutations in TK kinase (TK) Chinese hamster ovary (CHO) Mutations in HGPRT & V79 hypoxanthine guanine phosphoribosyltransferase (HGPRT) 23
IARC Classification, in vitro tests cont’d Test Endpoint Chromosomal alterations in vivo Heritable translocation test Translocations induced in (mice) germ cells Rat bone marrow Chromosomal aberrations clastogenesis in vivo in bone marrow cells in vivo Micronucleus test Appearance of micronuclei in bone marrow cells in vivo 24
8 Carcinogens
IARC Classification, in vitro tests cont’d Test Endpoint Chromosomal alterations in vitro Mitotic recombination, mitotic Conversion of crossing over, or mitotic gene heterozygous alleles to conversion in yeast homozygous state Induced chromosomal Visible alterations in aberrations in cell lines karyotype Sister chromatid exchange Visible exchange of differentially labeled sister chromatids 25
Ames’ Test
• Salmonella can normally synthesize histadine • Ames’ salmonella strain is genetically unable to synthesize histadine • The Ames’ test examines rate of loss of histadine- dependence due to mutation back to normal gene function allowing histadine synthesis • Generally performed with and w/out microsomes (hepatic homogenate) to evaluate metabolic activation
26
IARC Classification, cont’d
Animal experiments • Gold standard is the 2-year rodent bioassay • Preferences are a minimum of 2 species and both sexes.
27
9 Carcinogens
IARC Classification, cont’d Problems • Extrapolation from test tube to animal models • Extrapolation from animals to humans – Dose/Response relationship – Cell type differences – Metabolic differences
28
Group 1 “Known Human Carcinogens” (107) • Sufficient Human Evidence • Less than sufficient in humans but sufficient in animals and strong evidence in humans of a relevant mechanism.
29
Group 2A “Probable” (63)
• Limited Human Evidence and sufficient animal evidence • Inadequate human and sufficient animal evidence and a relevant mechanism in humans • Rarely: limited Human Evidence Alone
30
10 Carcinogens
Group 1: Agents and Groups of Agents (107 as of 05/12)
Benzo(a)pyrene
31
Antineoplastic drugs and other drug evaluated by the IARC Monograph Working Group
Cancer on which Group 1 Agent sufficient evidence in Established mechanistic events humans is based Busulfan Acute myeloid leukemia Genotoxicity (alkylating agent) Chlorambucil Acute myeloid leukemia Genotoxicity (alkylating agent) Cyclophosphamide Acute myeloid leukemia, Genotoxicity (metabolism to alkylating bladder agent) Melphalan Acute myeloid leukemia Genotoxicity (alkylating agent) Semustine Acute myeloid leukemia Genotoxicity (alkylating agent) (methyl-CCNU) Thiotepa Leukemia Genotoxicity (alkylating agent) Treosulfan Acute myeloid leukemia Genotoxicity (alkylating agent)
32
Antineoplastic drugs and other drug evaluated by the IARC Monograph Working Group Cancer on which Group 1 Agent sufficient evidence Established mechanistic events in humans is based MOPP* combined therapy Acute myeloid Genotoxicity (alkylating agent) leukemia, lung Etoposide in combination Acute myeloid Genotoxicity; translocation involving MLL with cisplatin and bleomycin leukemia gene (etoposide) Etoposide (Group 2A in 2000) Genotoxicity; translocation involving MLL gene Chlomaphazine Bladder Genotoxicity (alkylating agent, metabolism to 2-naphthylamine derivatives) Azathioprine non-Hodgkin Genotoxicity, immunosuppression lymphoma, skin Cyclosporin non-Hodgkin Immunosuppression lymphoma, skin, multiple other sites
*MOPP= chlormethine (mechlorethamine), vincristine (oncovin), procarbazine, and prednisone33
11 Carcinogens
Antineoplastic drugs and other drug evaluated by the IARC Monograph Working Group
Cancer on which Group 1 Agent sufficient evidence Established mechanistic events in humans is based Methoxsalen+ultraviolet Skin Genotoxicity following photo-activation light Plants containing Renal pelvis, ureter Genotoxicity; DNA adducts in humans, aristolochic acid A:T T:A transversion in TP53 in human tumors Aristolochic acid (Group 2A Genotoxicity; DNA adducts in animals are in 2000) the same as those found in humans exposed to plants, A:T T:A transversions in TP53, RAS activation Analgesic mixtures Renal pelvis, ureter (See phenacetin) containing phenacetin Phenacetin (Group 2A in Renal pelvis, ureter Genotoxicity, cell proliferation 2000) 34
Hormonal treatments assessed by the IARC Monograph Working Group
Group 1 agent Cancer on which sufficient Established mechanistic Other likely evidence in humans is based events mechanistic events Diethylstilbestrol Breast (exposure during Estrogen receptor- Epigenetic pregnancy), vagina and cervix mediated events (vagina, programming (exposure in utero) cervix), genotoxicity Estrogen-only Endometrium, ovary Estrogen receptor- Genotoxicity menopausal therapy mediated events Combined estrogen- Endometrium (risk diseases Receptor-mediated events Estrogen genotoxicity, progestogen with number of days/month of menopausal therapy progestogen use), breast Combined estrogen- Breast, cervix, liver Receptor-mediated events Estrogen genotoxicity, progestagen oral (endometrium & ovary hormone-stimulated contraceptives DECREASED) expression of human papillomavirus genes Tamoxifen Endometrium Estrogen receptor-mediated (breast DECREASED) events, genotoxicity
35
Evidence for carcinogenicity in humans and for geotoxicity as the main mechanism
Tumor sites with sufficient Evidence of genotoxicity Agent evidence in humans as the main mechanism
Aromatic amines 4-Aminobiphenyl Urinary bladder Strong Benzidine Urinary bladder Strong Dyes metabolized to benzidine Strong* 4.4’-Methylenebis(2-chloroaniline) Strong* 2-Naphthylamine Urinary bladder Strong Ortho-toluidine Urinary bladder Moderate Auramine production Urinary bladder Weak / lack of data Magenta production Urinary bladder Weak / lack of data
*Agents classified in Group 1 on the basis of mechanistic information 36
12 Carcinogens
Evidence for carcinogenicity in humans and for geotoxicity as the main mechanism
Tumor sites with sufficient Evidence of genotoxicity Agent evidence in humans as the main mechanism
PAH-related exposures Benzo(α)pyrene Strong* Soot (chimney sweeping) Skin, lung Moderate Coal gasification Lung Strong Coal-tar distillation Skin Strong Coke production Lung Strong Coal-tar pitches (paving, roofing) Lung Strong Aluminum production Lung, urinary bladder Weak / moderate†‡
*Agents classified in Group 1 on the basis of mechanistic information †Weak evidence in workers, but strong evidence for some chemicals in this industry ‡Due to the diversity and complexity of these exposure, other mechanisms may also be 37relevant
Evidence for carcinogenicity in humans and for geotoxicity as the main mechanism Tumor sites with sufficient Evidence of genotoxicity Agent evidence in humans as the main mechanism Other chemicals Aflatoxins Hepatocellular carcinoma Strong Benzene ANLL Strong Bis(chloromethyl)ether/chloromethyl Lung Moderate/Strong methylether 1,3-Butadiene Haematolymphatic organs Strong Dioxin(2,3,7,8-TCDD) All cancers combined** § 2,3,7,8-Pentachlorodibenzofuran *§ 3,3’,4,4’,5-Pentachlorobiphenyl § (PCB-126) ANLL = acute non-lymphocytic leukemia *Agents classified in Group 1 on the basis of mechanistic information §Strong evidence for an aryl hydrocarbon receptor (AhR)-mediated mechanism 38 **New epidemiological findings.
Evidence for carcinogenicity in humans and for geotoxicity as the main mechanism
Tumor sites with sufficient Evidence of genotoxicity Agent evidence in humans as the main mechanism Other chemicals Ethylene oxide Strong* Formaldehyde Nasopharynx Strong Leukemia¶** Moderate Sulfur mustard Lung Strong Vinyl chloride Hepatic angiosarcoma Strong Hepatocellular carcinoma
*Agents classified in Group 1 on the basis of mechanistic information ¶Particularly myeloid leukemia **New epidemiological findings.
39
13 Carcinogens
Evidence for carcinogenicity in humans and for genotoxicity as the main mechanism Tumor sites with sufficient Evidence of genotoxicity Agent evidence in humans as the main mechanism Other complex exposures Iron and steel founding Lung Strong* Isopropyl alcohol manufacture Nasal cavity Moderate using strong acids Mineral oils Skin Strong Occupational exposure as a Lung, urinary bladder, pleural Strong‡ painter mesothelioma Rubber manufacturing Leukemia, lymphoma**, urinary Strong‡ industry bladder, lung**, stomach** Shale oils Skin Weak / lack of data Strong inorganic acid mists Larynx Weak / lack of data *Agents classified in Group 1 on the basis of mechanistic information **New epidemiological findings. 40 ‡Due to the diversity and complexity of these exposure, other mechanisms may also be relevant
Metals, arsenic dusts and fibers assessed by the IARC Monograph Working Group
Tumor sites (or types) for Group 1 Agent which there is sufficient Established mechanistic events evidence in humans Arsenic and inorganic Lung, skin, urinary Oxidative DNA damage, genomic arsenic compounds bladder instability, aneuploidy, gene amplification, epigenetic effects, DNA-repair inhibition leading to mutagenesis Beryllium and Lung Chromosome aberrations, aneuploidy DNA beryllium compounds damage Cadmium and Lung DNA-repair inhibition, disturbance of cadmium compounds tumor-suppressor proteins leading to genomic instability Chromium (VI) Lung Direct DNA damage after intracellular compounds reduction to Cr (III), mutation, genomic instability, aneuploidy, cell transformation
41
Metals, arsenic dusts and fibers assessed by the IARC Monograph Working Group
Tumor sites (or types) for Group 1 Agent which there is sufficient Established mechanistic events evidence in humans Nickel compounds Lung, nasal cavity, and DNA damage, chromosome aberrations, paranasal sinuses genomic instability, micronuclei, DNA- repair inhibition, alteration of DNA methylation, histone modification Asbestos (chrysotile, Lung, mesothelioma, Impaired fiber clearance leading to crocidolite, amosite, larynx, ovary macrophage activation, inflammation, tremolite, actinolite generation of reactive oxygen and nitrogen and anthrophyllite) species, tissue injury, genotoxicity, aneuploidy and polyploidy, epigenetic alteration, activation of signaling pathways, resistance to apoptosis
42
14 Carcinogens
Metals, arsenic dusts and fibers assessed by the IARC Monograph Working Group
Tumor sites (or types) for Group 1 Agent which there is sufficient Established mechanistic events evidence in humans Erionite Mesothelioma Genotoxicity Silica dust, crystalline Lung Impaired particle clearance leading to in the form of quartz macrophage activation and persistent or crystobalite inflammation Leather dust Nasal cavity and paranasal sinuses Wood dust Nasal cavity and paranasal sinuses, nasopharynx
43
Evidence for carcinogenicity in humans of Groups 1 agents assessed – Personal Health
Tumor sites for which there is sufficient evidence Tobacco Smoking Oral cavity, oropharynx, nasopharynx, and hypopharynx, esophagus (adenocarcinoma and squamous-cell carcinoma), stomach, colorectum*, liver, pancreas, nasal cavity and paranasal sinuses, larynx, lung, uterine, cervix, ovary (mucinous)*, urinary bladder, kidney (body and pelvis), ureter, bone marrow (myeloid leukemia) Parental smoking Hepatoblastoma* (cancer in the offspring)
*New sites 44
Evidence for carcinogenicity in humans of Groups 1 agents assessed – Personal Health
Tumor sites for which there is sufficient evidence Second hand smoke Lung Smokeless tobacco Oral cavity, esophagus*, pancreas Areca nut Betel quid w/added Oral cavity, pharynx, tobacco esophagus Betel quid w/o added Oral cavity, tobacco esophagus* Alcohol consumption Oral cavity, pharynx, larynx, esophagus, liver, colorectum, female breast
*New sites 45
15 Carcinogens
Evidence for carcinogenicity in humans of Groups 1 agents assessed – Personal Health
Tumor sites for which there is sufficient evidence Acetaldehyde Esophagus*, head and associated with neck* alcohol consumption Chinese style salted Nasopharynx fish Indoor emissions Lung from household combustion of coal
*New sites
46
Radiation exposures with sufficient evidence in humans Tumor sites (and types) on Radiation type Major study populations which sufficient evidence is based Alpha-particle and beta-particle emitters Radon-222 and decay products General population Lung (residential exposure), underground miners Radium-224 and decay Medical patients Bone products Radium-226, radium-228, and Radium-dial painters Bone, paranasal sinus and mastoid decay products process (radium -226 only Thorium-232 and decay Medical patients Liver, extrahepatic bile ducts, gall products bladder, leukemia (excluding CLL) Plutonium Plutonium-production Lung, liver, bone workers CLL: chronic lymphocytic leukemia 47
Radiation exposures with sufficient evidence in humans
Tumor sites (and types) on Radiation type Major study populations which sufficient evidence is based Alpha-particle and beta-particle emitters Phosphorus-32 Medical patients Acute leukemia Fission products, including General population Solid cancers, leukemia strontium-90 following nuclear reactor accident Radioiodines, including Children and adolescents Thyroid iodine-131 following nuclear reactor accident
48
16 Carcinogens
Radiation exposures with sufficient evidence in humans
Tumor sites (and types) on which Radiation type Major study populations sufficient evidence is based X-radiation or Atomic bomb survivors, medical Salivary gland, esophagus, stomach, gamma-radiation patients, in-utero exposure colon, lung, bone, skin (BCC), female (offspring of pregnant medical breast, urinary bladder, brain and CNS, patients and of atomic bomb leukemia (excluding CLL), thyroid, survivors) kidney (atomic bomb survivors, medical patients), multiple sites (in-utero exposure Solar radiation General population Skin (BCC, SCC, melanoma) UV-emitting General population Skin (melanoma), eye (melanoma, tanning device particularly choroid and ciliary body) CLL: chronic lymphocytic leukemia BBC: basal-cell-carcinoma SCC: squamous-cell-carcinoma 49
Biological agents assessed by the IARC Monograph Working Group
Cancers for which there is Established mechanistic Group 1 Agent sufficient evidence in events humans Epstein-Barr Virus (EBV) Nasopharyngeal carcinoma, Cell proliferation, inhibition Burkitt’s lymphoma, of apoptosis, genomic extranodal NK/T-cell instability, cell migration lymphoma (nasal type), Hodgkin’s lymphoma Hepatitis B virus (HBV) Hepatocellular carcinoma Inflammation, liver cirrhosis, chronic hepatitis Hepatitis C virus (HCV) Hepatocellular carcinoma, Inflammation, liver cirrhosis, non-Hodgkin’s lymphoma* liver fibrosis
* Newly identified link between virus and cancer 50
Biological agents assessed by the IARC Monograph Working Group
Cancers for which there is Established mechanistic Group 1 Agent sufficient evidence in humans events
Kaposi’s sarcoma herpes Kaposi’s sarcoma*, primary Cell proliferation, inhibition virus (KSHV) effusion lymphoma* of apoptosis, genomic instability, cell migration Human immunodeficiency Kaposi’s sarcoma, non-Hodgkin’s Immunosuppression (indirect virus type 1 (HIV-1) lymphoma, Hodgkin’s action) lymphoma*, cancer of the cervix*, anus*, conjunctiva* Human papillomavirus type Carcinoma of the cervix, vulva, Immortalisation, genomic 16 (HPV-16)` vagina, penis, anus, oral cavity, instability, inhibition of and oropharynx & tonsil DNA damage response, anti- apoptotic activity *Newly identified link between virus and cancer `For other types, see next slide 51
17 Carcinogens
Group HPV types
Group HPV Types Comments Alpha HPV types 1 16 Most potent HPV type, known to cause cancer at several sites 1 18, 31, 33, Sufficient evidence for cervical cancer 35, 39, 45, 51, 52, 56, 58, 59 2A 68 Limited evidence in humans and strong mechanistic evidence for cervical cancer
52
Biological agents assessed by the IARC Monograph Working Group
Cancers for which there is Established mechanistic Group 1 Agent sufficient evidence in humans events
Human T-cell lymphotropic Adult T-cell leukemia and Immortalisation and virus, type-1 (HTLV-1) lymphoma transformation of T cells Heliobacter pylori Non-cardia gastric carcinoma, low- Inflammation, oxidative grade B-cell mucosa-associated stress, altered cellular turn- lymphoid tissue (MALT) gastric over and gene expression, lymphoma* methylation mutation Clonorchis sinemsis Cholangiocarcinoma* Opsithochis viverrini Cholangiocarcinoma Inflammation, oxidative stress, cell proliferation Schictosoma haemetobium Urinary bladder cancer Inflammation, oxidative stress,
*Newly identified link between virus and cancer 53
Oral Cavity
• Alcoholic beverages • Betel quid with tobacco • Betel quid without tobacco • Human papillomavirus type 16 • Tobacco, smokeless • Tobacco smoking
54
18 Carcinogens
Tonsil
• Human papillomavirus type 16
55
Pharynx
• Alcoholic beverages • Betel quid with tobacco • Human papillomavirus type 16 • Tobacco smoking
56
Nasopharynx
• Epstein-Barr virus • Formaldehyde • Salted fish, Chinese-style • Wood dust
57
19 Carcinogens
Digestive tract, upper
• Acetaldehyde associated with consumption of alcoholic beverages
58
Esophagus • Acetaldehyde associated with consumption of alcoholic beverages • Alcoholic beverages • Betel quid with tobacco • Betel quid without tobacco • Tobacco, Smokeless • Tobacco smoking • X-radiation, Gamma-radiation
59
Stomach
• Heliobacter pylori • Rubber production industry • Tobacco, Smokeless • Tobacco smoking • X-radiation, Gamma-radiation
60
20 Carcinogens
Colon and rectum
• Alcoholic beverages • Tobacco smoking • X-radiation, Gamma-radiation
61
Anus
• Human immunodeficiency virus type 1 • Human papillomavirus type 16
62
Liver and bile duct • Aflatoxins • Alcoholic beverages • Clonorchis sinensis • Estrogen-progestogen contraceptives • Hepatitis B virus • Hepatitis C virus • Opisthorchis viverrini • Plutonium • Thorium-232 and its decay products • Tobacco smoking (in smokers and in smokers’ children) • Vinyl chloride 63
21 Carcinogens
Gall bladder
• Thorium-232 and its decay products
64
Pancreas
• Tobacco, Smokeless • Tobacco smoking
65
Nasal cavity and paranasal sinus
• Isopropyl alcohol production • Leather dust • Nickel compounds • Radium-226 and its decay products • Radium-228 and its decay products • Tobacco smoking • Wood dust
66
22 Carcinogens
Larynx
• Acid mists, strong inorganic • Alcoholic beverages • Asbestos (all forms) • Tobacco smoking
67
Lung
• Aluminum production • Arsenic and inorganic arsenic compounds • Asbestos (all forms) • Beryllium and beryllium compounds • Bis(chloromethyl)ether; chloromethyl methyl ether (technical grade)
• Cadmium and cadmium compounds (cont’d)
68
Lung
• Chromium(VI) compounds • Coal, indoor emissions from household combustion • Coal gasification • Coal-tar pitch • Coke production • Hematite mining (underground) (cont’d)
69
23 Carcinogens
Lung
• Iron and steel founding • MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) • Nickel compounds • Painting • Plutonium • Radon-222 and its decay products (cont’d)
70
Lung
• Rubber production industry • Silica dust, crystalline • Soot • Sulfur mustard • Tobacco smoke, secondhand • Tobacco smoking • X-radiation, gamma-radiation
71
Bone
• Plutonium • Radium-224 and its decay products • Radium-226 and its decay products • Radium-228 and its decay products • X-radiation, gamma-radiation
72
24 Carcinogens
Skin Melanoma
• Solar radiation • Ultraviolet-emitting tanning devices
73
Skin (non-melanoma malignant neoplasms) • Arsenic and inorganic arsenic compounds • Azathioprine • Coal-tar distillation • Coal-tar pitch • Cyclosporine • Methoxsalen plus Ultraviolet A • Mineral oils, untreated or mildly treated • Shale oils • Solar radiation • Soot • X-radiation, gamma-radiation 74
Mesothelium (pleura and peritoneum)
• Asbestos (all forms) • Erionite • Painting
75
25 Carcinogens
Endothelium (Kaposi sarcoma)
• Human immunodeficiency virus type 1 • Kaposi sarcoma herpes virus
76
Breast
• Alcoholic beverages • Diethylstilbestrol • Estrogen-progestogen contraceptives • Estrogen-progestogen menopausal therapy • X-radiation, gamma-radiation
77
Vulva
• Human papillomavirus type 16
78
26 Carcinogens
Vagina
• Diethylstilbestrol (exposure in utero) • Human papillomavirus type 16
79
Uterine cervix
• Diethylstilbestrol (exposure in utero) • Estrogen-progestogen contraceptives • Human immunodeficiency virus type 1 • Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 • Tobacco smoking
80
Endometrium
• Estrogen menopausal therapy • Estrogen-progestogen menopausal therapy • Tamoxifen
81
27 Carcinogens
Ovary
• Asbestos (all forms) • Estrogen menopausal therapy • Tobacco smoking
82
Penis
• Human papillomavirus 16
83
Kidney
• Tobacco smoking • X-radiation, gamma-radiation
84
28 Carcinogens
Renal pelvis and ureter
• Aristolochic acid, plants containing • Phenacetin • Phenacetin, analgesic mixtures containing • Tobacco smoking
85
Urinary bladder
• Aluminum production • 4-Aminobiphenyl • Arsenic and inorganic arsenic compounds • Auramine production • Benzidine • Chlornaphazine • Cyclophosphamide (cont’d)
86
Urinary bladder • Magenta production • 2-Naphthylamine • Painting • Rubber production industry • Schistosoma haematobium • Tobacco smoking • ortho-Toluidine • X-radiation, gamma-radiation 87
29 Carcinogens
Eye
• Human immunodeficiency virus type 1 • Ultraviolet-emitting tanning devices • Welding
88
Brain and central nervous system
• X-radiation, gamma-radiation
89
Thyroid
• Radioiodines, including Iodine-131 • X-radiation, gamma-radiation
90
30 Carcinogens
Lymphoid, hematopoietic and related tissue: Leukemia &/or lymphoma
• Azathioprine • Benzene • Busulfan • 1,3-Butadiene • Chlorambucil • Cyclophosphamide • Cyclosporine (cont’d)
91
Lymphoid, hematopoietic and related tissue: Leukemia &/or lymphoma
• Epstein-Barr virus • Etoposide with cisplatin and bleomycin • Fission products, including Strontium-90 • Formaldehyde • Heliobacter pylori • Hepatitis C virus • Human immunodeficiency virus type 1(cont’d)
92
Lymphoid, hematopoietic and related tissue: Leukemia &/or lymphoma
• Human T-cell lymphotropic virus type 1 • Kaposi sarcoma herpes virus • Melphalan • MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) • Phosphorus-32 • Rubber production industry (cont’d)
93
31 Carcinogens
Lymphoid, hematopoietic and related tissue: Leukemia &/or lymphoma
• Semustine (methyl-CCNU) • Thiotepa • Thorium-232 and it’s decay products • Tobacco smoking • Treosulfan • X-radiation, gamma-radiation
94
Multiple sites (unspecified)
• Cyclosporine • Fission products, including Strontium-90 • X-radiation, gamma-radiation (exposure in utero)
95
All cancer sites (combined)
• 2,3,7,8-Tetrachlorodibenzo-para-dioxin
96
32 Miscellaneous Toxins
ACMT Board Review
Miscellaneous Toxicants
Brandon Wills, DO, FACEP, FACMT Fellowship Director, Medical Toxicology Department of Emergency Medicine VCU Medical Center Virginia Poison Center VCU TOX 1
2.2.10 Miscellaneous Toxicants 2.2.10.1 Acrolein 2.2.10.2 Acrylamides 2.2.10.3 Acrylates 2.2.10.4 Amines 2.2.10.5 Aniline Compounds 2.2.10.6 Azides 2.2.10.7 Bromide Compounds 2.2.10.8 Butadienes 2.2.10.9 Carbon Disulfide 2.2.10.10 Chlorates 2.2.10.11 Coal Tar Products 2.2.10.12 Diamines 2.2.10.13 Dibromochloropropane (DBCP) 2.2.10.14 Dimethylacetamide (DMAC) 2.2.10.15 Dimethylformamide (DMF) 2.2.10.16 Dinitrobenzene 2.2.10.17 Dinitrotoluene (DNT) 2.2.10.18 Epichlorohydrin 2.2.10.19 Ethylene Dibromide (EDB) 2.2.10.20 Ethylenediamine (EDA) 2.2.10.21 Fluoride Compounds 2.2.10.22 Fuels 2.2.10.23 Hexachloro-1,3-Butadiene (HCBD) 2.2.10.24 Isocyanates (eg, toluene diisocyante) 2.2.10.25 Maleic Anhydride 2.2.10.26 Mercaptans 2.2.10.27 Methylene Diamine (MDA) 2.2.10.28 Nitriles 2.2.10.29 O-Phenylenediamine (OPD) 2.2.10.30 Phosphorus/phosphides 2.2.10.31 Phthalates 2.2.10.32 Polymers 2.2.10.33 Resins 2.2.10.34 Styrene 2.2.10.35 Trimellitic Anhydride 2.2.10.36 Triorthocresylphosphate (TOCP) 2 2.2.10.37 Xylidine
Our Gameplan
Organize your memory
Using study aids (quick look at flashcards) 60 min: brief review- focus on test rather than content
20 min: Miscellaneous Toxicants Jeopardy overview
3
1 Miscellaneous Toxins
Sources
Dr. Sean Bryant
Dr. Mike Greenburg
Sullivan, 2nd Ed Greenburg, 2nd Ed
My board review notes
http://pubchem.ncbi.nlm.nih.gov/ (structures)
4
Legend for this talk
U= Uses
I= Industry
T= Toxicity
M= Miscellaneous factoids
5
Acrylaldehyde, propenal, allyl aldehyde Acrolein Ethylene aldehyde, aqualin, (CH2=CHCHO)
Acrolein = Acrid = IRRITATING
I: Contact herbicide I: WWI Lacrimator
T- Water soluble irritant
T- Cellular toxin via oxygen free radicals
M- Metabolite of cyclophosphamide
6
2 Miscellaneous Toxins
Propenamide, acrylic amide, Acrylamides akrylamid Heating Starches U- Polymer production (SDS-PAGE), flocculator
T- Axonopathy T- Dermatitis (peeling, red/blue, hyperhidrosis)
T- IARC 2A (poss gyn CA) M- Polymer = non-toxic, Monomer= toxic
7
Acrylates, methylacryates, Cyanoacrylates Acrylates Ethyl, methyl, 2-ethyl hexyl, butyl…
U- Cross-linking properties (plexiglass)
T- Irritant (skin, MM, and pulmonary) T- Contact dermatitis
M- Penetrates latex/ rubber easily
8
Dimethylamine Trichlorotriethylamine Benzidine Benzidine Amines β-naphthylamine
Dimethylamine
AZO Dyes
-Vulcanization
9
3 Miscellaneous Toxins
Aniline 4-chloroaniline Aniline Compounds 4-aminophenol Nitrobenzene 4,4’-Methylene dianiline Aniline
U- Precursor for polyurethane, indigo= blue jean die I- Smells like rotten fish
T- Acute: MetHb, irritant
T- Chronic: Bladder CA Methylenedianiline: Hepatitis (Epping jaundice)
Due to contaminated bread T- Aniline (Spain) Toxic oil syndrome Due to contaminated rapeseed oil (interstitial pulm dz) 10
Azides
U- Airbag accelerant; pesticde, explosives I- Labs and manufacturing plants
T- Cellular asphyxiant, resp failure/ pulm edema T- Eye irritant
11
Bromide Compounds
U- Photographic, hot tub chemicals, fumigants...
T- Crosses membrane faster than Cl, replacing Cl
causing sedation/ neuropsych (KBr- 19th century)
T (chronic)- neuropsych, acne (30% facial), axonopathy
M- Low anion gap (false high Cl)
12
4 Miscellaneous Toxins
1,3-butadiene Hexachloro-1,3- butadiene Butadienes Many others Butadiene
U- Monomer for plastics (ABS plastic*), tobacco smoke
T- Irritant (skin and mucous membranes)
T- IARC 2A (lymphohematopoetic, testicular, thyroid, mammary)
*ABS: Acrylonitrile-butadiene-styrene
13
Carbon Disulfide U- Volatile organic solvent I- Rayon, fumigation
T- Acute: Irritant (defatting), disulfiram rxn T- Chronic: 1. Distal axonopathy 2. Optic nerve (resembles optic neuritis) 3. CV (HTN, CAD) 4. Repro (SAB, prematurity, decreased libido)
14
Potassium chlorate Calcium chlorate Chlorates Sodium perchlorate, etc
U- Oxidizer, pesticide, explosives, bleaching paper
U- Prior uses: pryotechnics, mouthwash
T- Oxidizer= MetHb, hemolysis, renal failure
M- FYI- Perchlorates= Also oxidizers but more stable
15
5 Miscellaneous Toxins
Coal Tar Products
Sources: wood creosote= beach wood
(phenol, cresols, guaiacols, xylenols)
coal tar creosote= by-product of coal tar
(85% polycyclic aromatic hydrocarbons (PAH))
U- Wood: wood protectant
Coal tar: wood preservative (railroad ties), Rx psoriasis
T- Dermal irritant, pulmonary= restrictive/ obstructive
Cancer d/t PAH (lung, oral, stomach, bladder, scrotal, skin)
16
Diamine (Hydrazine) Hexamethylene diamine Toluene-2,4-diamine (TDI) 2-methyl-1,4- benzenediamene Diamines TDI Hydrazine
U- Hydrazine= Rocket fuel (reducer), insecticides, plastics
U- P-phenylenediamine= henna & all hair dyes...
T- Irritant/ sensitizer (dermal & pulmonary), lupus-like
T- Hydrazine=INH (seizures, hepatitis, MetHb, skin sensitizer)
17
Dibromochloropropane (DBCP)
U- Nematicide (D/C’d in 1979)-> replaced by dibromoethane
T- Dermal / ocular irritant
T- Testicular (aspermia, oligospermia)
De Balls Can’t Produce (DBCP)
18
6 Miscellaneous Toxins
Dimethylacetamide (DMAC)
U- Paint remover, solvent for plastics (dissolves PVC)
Smells like fish/ ammonia
T- Potent hepatotoxin: ↑ LFT, jaundice, hepatomegaly, liver necrosis
T- Irritant: esophagitis, conjunctivitis, dermal burn
19
Dimethylformamide (DMF) “Universal Solvent”
U- Penetrates most plastics (makes them swell) I- Acrylic fiber production, paint strippers Vehicle for transdermal drug delivery
T- Potent hepatotoxin (CLN, steatosis) T- Disulfiram rxn T- Pulm irritant
20
Dinitrobenzene
U- EXPLOSIVES, spandex, dyes
T- Retrobulbar neuritis & optic neuropathy
T- MetHb (potent)
T- Subacute hepatic necrosis, aplastic anemia
T- May have bitter almond odor, hair/skin/ eye yellowing
21
7 Miscellaneous Toxins
Dinitrotoluene (DNT)
U- EXPLOSIVES, diisocyanate production, dyes
T- Uncouples oxidative phosphorylation
T- MetHb
T- Hemolytic anemia
T- Retrobulbar & optic neuropathy
M- Turns skin yellow
22
Epichlorhydrin
U- Highly reactive plastics production I- Production of dye, lubricants, adhesives, drugs
T- Strong Irritant (sensitizer): respiratory, dermal, ocular T- Nephrotoxicity, CNS depression, hypotension
M- Penetrates rubber M- Sweet, chloroform odor has poor warning property
23
Ethylene Dibromide (EDB) (AKA Dibromoethane)
U- Replaced dibromochloropropane as nematicide
U- Fumigant (grain- banned 1948), fire extinguishers, lead scavenger in gasoline
T- Hepatotoxicity (GSSH depletion)
T- Strong irritant (dermal, pulmonary)
24
8 Miscellaneous Toxins
Ethylenediamine (EDA)
U- Dyes, solvent, emulsifier (skin creams/ latex)
U- Drug production:
(EDTA, imidazolines, aminophylline, antihistamines)
T- Sensitizer (contact dermatitis, occ asthma)
T- MetHb
25
Fluoride Compounds
U- NaF: electroplating, toothpaste/ water additive HF: cleaning brick/ rust, glass etching
T- Chelates divalent cations (Ca++, Mg++), results in ↓ Mg/ Ca, ↑ K = ventricular fibrillation
T- Chronic= fluorosis: bone density, calcification of ligaments, hyperostosis, white-brown dental spots (axial osteosclerosis/ nerve compression) 26
Fuels
U- Energy-producing hydrocarbons
T- PULMONARY (pneumonitis)
M- Jet fuels (kerosene, benzene, xylene, toluene)
JP-7 & JP-8 ∼ pure kerosene
27
9 Miscellaneous Toxins
Hexachloro-1,3-Butadiene (HCBD)
U- Heat transfer liquid (transformers/ hydraulic fluid)
U- Fumigant in vineyards (don’t confuse with Bordeaux= copper sulfate)
T- Irritant (Pulmonary hemorrhage)
T- Hepatic fatty degeneration
T- Renal tubular necrosis, tubular adenomas
28
Methylisocyanate (MIC) Toluene diisocyanate (TDI) Isocyanates MIC
U- Producing polyurethane polymers
(don’t confuse with aniline also a polyurethane precursor) U- Methylisocyanate (MIC)- production of carbamates
T- MIC: Major irritant (pulm, derm, ocular) T- TDI: #1 Occupational asthma (HP)
29
Maleic Anhydride
U- Enamels, bonding, synthesis of malathion
T- Allergic sensitizer (occupational asthma)
Hypersensitivity pneumonitis (HP)= extrinsic allergic alveolitis= Immunologic
T- Irritant (dermal, ocular)
30
10 Miscellaneous Toxins
Mercaptans Mercaptomethane
Chemicals with a –SH group (noxious≈ cabbage)
U- Odorant (natural gas= t-butylmercaptan) U- Intermediate in synthesis of fuels, pesticides…
T- Irritant (derm, MM, respiratory)
T- MetHb & hemolysis (worse in G6PD)
31
acetonitrile propane nitrile Nitriles butanenitrile Acetonitrile Chemicals with a –CN
U- Solvents (eg. artificial nail remover), reagents
T- Liberation of –CN Cellular asphyxiant T- Irritants (derm, MM, ocular) M- Prolonged observation for delayed CN toxicity
32
O-Phenylenediamine (OPD) P-Phenylenediamine (PPD)
*This compound is also listed under “Diamines”* PPD
U- OPD: dyes, fungicides, vet antihelminthic U- PPD: hair dyes and henna tattoos
T- OPD=severe urticaria/dermatitis (eye blindness)
T- PPD= bladder cancer
33
11 Miscellaneous Toxins
Phosphorus Red Phosphides Zn Phosphide Phosphorus
U- Making phosphates, detergents, fertilizer, match tips (red)
U- Zn & Al phosphide: Insecticides, rodenticides
T- Yellow: strong oxidizer, causes burns (Red is benign)
Ingestion: 1. “smoking”, glowing stool, smells of garlic
2. Asymptomatic (hrs-weeks) 3. Hepatic/ renal failure Chronic: “Phossy Jaw”- mandibular necrosis
T- Phospine gas: cellular asphyxiant + pulm edema + #3 above 34
Phthalates diethylhexyl phthalate
U- Plasticizing for vinyl, softens PVC
T- Controversial whether phthalates have health effects. Some claim association with asthma, “sick- building syndrome”, or endocrine problems but little supporting data
T- Diethylhexyl Phthalate (DEHP)= occ asthma
35
Polymers tetrafluoroethylene
*Diverse group of plastics*
One class= Fluoropolymer plastics:
Polytetrafluoroethylene (PTFE = Teflon)
T- Polymer Fume Fever (heating polymers)
-Pulm irritant, flu-like syndrome (similar to MFF)
-Resolves in 24-48 hrs
36
12 Miscellaneous Toxins
Resins methylenedianiline
Resins = Plastics
Combustion can liberate: CO, CN, phosgene
Methylenedianiline – Toxic hepatitis (Epping Jaundice)
Anhydrides – Occupational pneumonitis
37
Styrene
U- Styrene = Styrofoam
Also ABS, SBR plastics
T- “Styrene Sickness”: HA/fatigue/weakness, intoxicated after exp to vapor
T- Peripheral neuropathy
T- CNS (balance, memory, color vision) T- Chronic= Hearing loss
38
Trimellitic Anhydride
U- Plasticizer for polymers (PVC)
T- Sensitizer/ irritant; 4 syndromes:
1. Asthma/ rhinitis (IgE) 2. Irritant syndrome (dust/ fumes)
3. Late respiratory systemic syndrome (LRSS)
“Trimellitic Flu”- Like MFF, 4-12 hours after shift
4. Hypersensitivity pneumonitis + hemolytic anemia
“Pulmonary disease- anemia” (PDA)
Dyspnea, cough, hemoptysis, anemia May lead to restrictive lung dz; pulm hemosiderosis 39
13 Miscellaneous Toxins
Triorthocresylphosphate (TOCP) U- Plasticizer in lacquer, hydraulic fluid
T- Weak AchE inhibitor (like organophosphate)
Inhibits neuro-target-esterase (NTE)
T- Delayed sensory-motor neuropathy
“O-P ester induced delayed neurotoxicity (OPIDN)”
M- Jamaican Ginger (Jake) adulterated by TOCP
“Jake Walk”= Jake leg paralysis M- Morocco: OPIDN after TOCP adulterated cooking oil 40
Xylidine O-xylidine Xylidine 2-6-methylaniline
U- Making dyes/ pharmaceuticals, gas additive…
T- Acute: MetHb, cyanosis, intoxication
T- Chronic: Liver/ renal damage (animals)
41
Now…
Group by some reoccurring themes
42
14 Miscellaneous Toxins
Irritants
- Acrolein
- Acrylates
- Epichlorohydrin
- Ethylene Dibromide (EDB)
- Ethylenediamine
- Methylisocyanate (MIC)
- Mercaptans
-Many more
-So many, decide if this category works for you...
43
Cancer Causing
-Acrylamides (2A)
-Aromatic Amines (Benzidine, β-naphthylamine) (1): bladder
-Aniline (1): bladder
-P-Phenylenediamine (PPD): bladder, leukemia
-Butadienes (2A): lymphohematopoetic
-Coal tar: lung, oral, stomach, bladder, scrotal, skin
-Vinyl Chloride: Angiosarcoma of liver
-CCl4: Liver
44
Peripheral Neuropathy
-Acrylamide (A)
-Bromide (Methyl) (A) -Carbon disulfide (A)
-Styrene (?)
-TOCP
-Trichloroethylene (M)
45
15 Miscellaneous Toxins
Hepatotoxins
-Dimethylacetamide (DMAC): Necrosis, jaundice
-Dimethylformamide (DMF): CLN, steatosis
-Hexachloro-1,3-Butadiene (HCBD): fatty degen -Phosphorus (yellow or white)
-Xylidine (in animals; also renal damage)
-Methylenedianiline: Hepatitis (epping jaundice)
46
MetHb Inducers
-Chlorates
-Dinitrobenzene (potent)
-Dinitrotoluene (DNT)
-Ethylenediamine
-Mercaptans
-Xylidine
47
Sensitizers Pulmonary= Occupational Asthma
- Anhydrides: occupational pneumonitis (HP)
- Maleic Anhydride: Allergic & hypersensitivity pulm dz
- Trimellitic Anhydride: Asthma, “Trimellitic Flu” (HP)
- Ethylenediamine (EDA): occup asthma, contact dermatitis
- Toluene diisocyante (TDI)/ isocyanates: (#1 occ asthma)
- Diethylhexyl Phthalate (DEHP): occ asthma
48
16 Miscellaneous Toxins
Hypersensitivity Pneumonitis (HP) Some overlap with previous slide
- Anhydrides/ Maleic Anhydride
- Trimellitic Anhydride - Isocyanates (TDI, MDI)
49
50
VCU TOX 51
17 Accreditation Statement The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Alabama School of Medicine designates this educational activity for a maximum of 22.5 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Alabama School of Medicine is an equal opportunity/affirmative action institution.
Program Objectives: • Present study content specifically designed for the medical toxicology subspecialty exam offered jointly by ABEM,ABP, and ABPM • Present a comprehensive review of medical toxicology • Allow attendees to gain new insight into current clinical issues
Target Audience: Physicians preparing for the biennial certification and recertification examination in Medical Toxicology, and others with an interest in medical toxicology.
10645 N. Tatum Blvd., Suite 200-111, Phoenix, AZ 85028, T: 623.533.6340, E: [email protected] www.acmt.net